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Abstract
Characterization of the Biochemical Properties of Nudt8, a Novel CoA-degrading Enzyme
that Localizes to the Mitochondria

Evan Kerr
Coenzyme A (CoA) is a vital cofactor that is required for a variety of metabolic reactions
including the TCA cycle and the synthesis and oxidation of fatty acids, amino acids and ketone
bodies. The importance of CoA is underscored by its tight regulation, as prolonged elevations or
inability to synthesize adequate amounts of this cofactor lead to severe metabolic dysfunction.
Regulation of CoA biosynthesis has been extensively characterized, however less is known about
regulation of CoA and its thioesters via degradation. Presently, two CoA-degrading enzymes,
Nudt7 and Nudt19 have been identified as regulators of the peroxisomal pool of (acyl-)CoA in the
liver and kidneys, respectively. In addition to the peroxisomes, pools of CoA and (acyl-)CoAs
exist in the mitochondria and cytosol. Presently, no CoA-degrading enzymes localizing to these
compartments have been identified. Nudt8 has been annotated as CoA-degrading enzyme due
to its similarity to Nudt7. The CoA-binding motif and Nudix box are highly conserved between
Nudt8 and Nudt7; however, the ability of Nudt8 to degrade (acyl-)CoAs had not been established
experimentally. We were able to successfully express and purify recombinant Nudt8 and, using
enzymatic assays, we confirmed that this enzyme is a CoA diphosphohydrolase specific for free
CoA and medium chain acyl-CoAs. Furthermore, we were able to show that Nudt8 localizes to
the mitochondrial matrix, positioning it to regulate the largest pool of (acyl-)CoAs in the cell. This
research identified a novel CoA-degrading enzyme as a novel means through which mitochondrial
CoA, and thus mitochondrial metabolism, is regulated.
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Acetyl-CoA transporter 1

CBP

CREB-binding protein

CDCA

Chenodeoxycholic acid
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Coenzyme A

COASY

CoA synthase
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Carnitine octanolytransferase

DP-CoA

Dephospho-CoA
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Endoplasmic reticulum

GAPDH

Glyceraldehyde-3-phosphate dehydrogenase

mBB

Monobromobimane
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Mitochondrial targeting sequence

NBIA

Neurodegeneration with brain iron accumulation

PANK

Pantothenate kinase

PKAN

Pantothenate Kinase-Associated Neurodegeneration

PI3K

Phosphoinositide 3- Kinase

PPARα

Peroxisome proliferator-activated receptor α
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Chapter I: Literature review

Introduction
Coenzyme A (CoA) is an essential cofactor that binds and activates organic acids within
the cell for a multitude of reactions involved in energy metabolism (1). CoA is synthesized in its
free, unacylated form from pantothenic acid (vitamin B5), ATP, and cysteine in a five-step pathway
discussed in detail below (1). The reactive thiol of CoA forms thioester bonds with the carboxylic
group of a multitude of compounds. Hydrolysis of the resulting thioester bond is energetically
favorable (-32-36 kJ/ mol) and it is used to drive hundreds of reactions (2,3). Within the cell, CoA
and its thioesters are required for a variety of metabolic pathways including the tricarboxylic acid
(TCA) cycle, fatty acid β-oxidation, lipogenesis, acetylcholine synthesis, as well as ketone body
synthesis and oxidation. Additionally, through acylation of proteins, CoA thioesters can regulate
protein function, protein localization, stability, and protein-protein interactions (4,5). Under
conditions of oxidative stress, the thiol of free CoA can directly react with cysteines of target
proteins, which is referred to as ‘CoAlation’ (6). Free CoA and acyl-CoAs can also regulate
metabolic pathways through allosteric regulation of key enzymes interactions with target proteins,
allowing for fine tuning of metabolic activities within the cell (7,8).
At the whole tissue level, total CoA levels (free CoA and acyl-CoAs) dynamically change
with the nutritional state. In the liver and kidneys, the fasted state is associated with increased
CoA synthesis that promotes β-oxidation, ketogenesis, and gluconeogenesis (9). Conversely, the
switch from fatty acid to glucose oxidation is promoted, in the fed state, through a net decrease
in free and acyl-CoAs (10). The net decrease in CoA occurs from both inhibition of CoA synthesis
and increasing CoA degradation (10). Through coordination of synthesis and degradation, total
CoA levels are tightly regulated, which allows the cell to adapt to different metabolic states. The
importance of CoA homeostasis is underscored by the fact that prolonged elevations of total CoA
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levels contribute to excess hepatic fatty acid oxidation and gluconeogenesis seen in Type 2
Diabetes (11). Conversely, genetic or chemical inhibition of CoA synthesis results in a rapid
decrease in tissue total CoA levels, inhibition of fatty acid oxidation, and severe fasting
hypoglycemia (9,12). Thus, tight regulation of CoA and acyl-CoA levels is essential for metabolic
regulation of the cell.
Subcellular Distribution of CoA
CoA and Acyl-CoA Pools
CoA biosynthesis is ubiquitous and generate free CoA, which can then be used to activate
organic acids as acylCoAs (Fig. 1.1). The
concentration

of

total

CoA changes with the
metabolic needs of the
cell/tissue/organ
(13,14). Within the cell,
CoA and its derivatives
are found in three major
subcellular pools in the
mitochondria, cytosol,
and

peroxisomes.

These pools support
processes
specific

that

are

to

each

compartment.

The

mitochondria

Figure 1.1: Compartmentalization of CoA. The initial steps of CoA synthesis
take place in the cytosol. The final steps of CoA synthesis are catalyzed by
CoA synthase, which has been annotated to reside in both the mitochondrial
matrix and outer membrane. Thus, it is unclear where the final two steps of
CoA synthesis take place. The mitochondrial CoA pool contains as much as
80% of the cellular CoA pool. The peroxisomal CoA pool is the second largest
pool of CoA in the cell supporting fatty acid oxidation and bile acid synthesis.
Both the peroxisomes and the mitochondria contain CoA-degrading Nudix
hydrolases that act to regulate CoA dependent reactions occurring within the
organelle. The cytosol/ nuclear pool is the smallest pool of CoA used for
lipogenesis and acetylation of proteins. Finally, the endoplasmic reticulum
contains a small pool of acetyl CoA utilized for post translational modifications
mediating protein stability.

contain
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the largest pool of acyl-CoA. It is estimated that in the heart, the mitochondria contain as much
as 95% of the total cellular CoA with the remaining 5% divided between the cytosol and
peroxisomes (10). In the liver, 80% of the (acyl-)CoA pool is mitochondrial, with the remaining
20% allocated to the cytosol and peroxisomes (15-17). The mitochondrial CoA/acyl-CoA pool
supports a variety of metabolic pathways including fatty acid β-oxidation, ketone synthesis,
gluconeogenesis, and the TCA cycle. The cytosolic concentration of total CoA is estimated to be
0.106- 0.140 mM support processes such as lipid synthesis (15,16,18). Nuclear pores allow
cytosolic (acyl-)CoAs to freely move between the cytosol and nucleus where histone
aceyltransferases catalyze the acyl-CoA dependent transfer of acyl-groups to lysines on histones
as a means to regulate gene expression (19). The peroxisomal (acyl-)CoA pool is utilized for the
oxidation of very long chain fatty acids and the final steps in bile acid synthesis (17,20). Finally,
the endoplasmic reticulum (ER) contains a small pool of acetyl-CoA to act as acetyl-donor for
acetyltransferases that modify ER proteins. Acetylation of ER proteins acts as a quality control
mechanism regulating protein stability (21).
Mitochondrial CoA Transporters:
CoA species are unable to passively diffuse across lipid membranes, and the
mitochondrial and peroxisomal CoA/acyl-CoA pools are formed through specific transporters.
Acyl-CoAs entering the mitochondria for oxidization must first be converted to acyl-carnitines
allowing them to be transported across the inner mitochondrial membrane via carnitine acylcarnitine translocase (22). Once in the mitochondrial matrix, the ester bond linking the carnitine
and the acyl- group is cleaved, reforming the acyl-CoA via carnitine palmitoyl transferase 2 (22).
Pools of free CoA in the mitochondria and peroxisomes are formed via transporters belonging to
the Solute Carrier Family 25 (SLC25) superfamily (23). To date, two mitochondrial transporters
involved in the transport of CoA species have been identified, SLC25A42 and SLC25A16 (24,25).
In humans, mutations of SLC25A42 results in a wide range of symptoms ranging from muscle
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weakness and lactic acidosis to developmental delay, encephalopathy, and epilepsy (26-28). In
vitro reconstitution and analysis of recombinant SLC25A42 indicated that it catalyzes a counter
exchange of free CoA (Km = 71± 10 µM) or dephospho-CoA (Km = 64 ± 9 µM) for 3’,5’-ADP (Km =
55 ± 8 µM) (24). Deletion of Leu5P, a mitochondrial CoA transporter in yeast, resulted in a 15fold decrease in total CoA in the mitochondria resulting in the inability to utilize fatty acids as
substrates (25). The inability to utilize fatty acids was rescued with expression of the human
transporter SLC25A42 (24). These results support the conclusion that Leu5P and SLC25A42
function to import free CoA into the mitochondrial matrix (24). Less is known about SLC25A16, a
second mitochondrial free CoA transporter. In vitro expression and reconstitution of SLC25A16
has not been successful. However, its ability to transport free CoA into the mitochondria was also
shown in the Leu5P deficient yeast model (25). Expression of SCL25A16 was able to partially
rescue the CoA-deficient phenotype by increasing the mitochondrial total CoA (25). The cytosolic
acyl-CoA/CoA pool was unaffected, suggesting that the effect of SCL25A16 maybe specific to the
mitochondrial (acyl-)CoA pool.
The first three steps of CoA synthesis are catalyzed by enzymes in the cytosol. The final
two steps of CoA synthesis are catalyzed by CoA synthase (Coasy), a bifunctional enzyme that
localizes to the mitochondria (29). It was previously shown that Coasy localizes to the outer
membrane, with the active site exposed to the cytosol; however, more recently, Coasy has also
been shown to localize to the mitochondrial matrix (29-31). The discovery of Coasy in the
mitochondrial matrix raises the questions of where the primary site of CoA synthesis is and what
the role of these mitochondrial transporters is in the distribution of newly synthesized CoA to the
rest of the cell. If Coasy localized to the outer-mitochondrial membrane, the final CoA produced
by Coasy would be released into the cytosol and mitochondrial transporters would function to
import CoA into the mitochondria. This hypothesis is supported by the finding that SLC25A16
rescues mitochondria total CoA levels without effecting cytosolic levels. However, determining the
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submitochondrial localization of Coasy is essential to establish where the final two steps in CoA
biosynthesis occurs, which will provide insight into whether these transporters function to import
CoA into the mitochondria, or export de novo synthesized CoA into the cytosol.
Peroxisomal CoA Transporters:
Like the mitochondria, the peroxisomal pool of free CoA is imported from the cytosol via
SLC25 transporters. The peroxisomes also have a family of ATP Binding Cassette (ABCD 1-3)
transporters that function to import acyl-CoAs into the peroxisome. These ABCD proteins bind
long chain acyl-CoAs including the thioesters of linear, branched-chain and dicarboxylic fatty
acids and hydrolyze their thioester bond; the imported fatty acid is thought to be re-acylated once
inside the peroxisome (32). While the ABCD1-3 transporters import acyl-CoAs into the
peroxisomes, SLC25A17 is potentially a transporter for free CoA. In vitro reconstitution of
SLC25A17 found that this transporter catalyzes a counter exchange reaction exchanging ADP for
CoA (19.6± 3.8 µM), dephospho-CoA (14.4 ± 5.4 µM), FAD (2.6 ± 1.3 µM), FMN (10.2 ±3.3 µM)
and 3’,5’-ADP (0.78 ± 0.1 mM) (33). Deletion of SLC25A17 in zebra fish resulted in impaired
oxidation of long chain fatty acids indicating, that it functions to import CoA and other cofactors to
drive peroxisomal CoA-dependent processes (34). One of the primary functions of peroxisomes
is the initial oxidation of very long-chain fatty acids, which are then completely oxidized in the
mitochondria. Following oxidation in the peroxisomes, short- and medium-chain acyl-CoAs are
converted to the corresponding acyl-carnitine by carnitine acetyltransferase (short chain acylCoAs with 2-4 carbons), or carnitine octanoyltransferase (medium- chain acyl-CoAs with up to 10
carbons) for complete oxidation in the mitochondria (35,36).
Endoplasmic Reticulum CoA Transporters:
In the ER, a small pool of acetyl-CoA is present to act as acetyl-donor for
acetyltransferases modifying proteins within the ER. Acetylation of ER proteins acts as a quality
control mechanism regulating protein stability (37). Acetyl-CoA is transported into the ER by the
5

transporter AT-1 (38). Unlike other members of the SLC family of proteins, AT-1 is specific for
acetyl-CoA (38). The levels of acetyl-CoA within the ER are tightly regulated. Drastic decreases
in acetyl-CoA levels induce autophagy and reduce cell viability. Mutations of AT-1 in murine
models that lead to its inability to import acetyl-CoA result in decreased ER protein acetylation
(38). This, in turn, causes developmental deficits, muscle weakness, and increased immune
response through T-cell activation (39). Conversely, overexpression of AT-1 increased acetylation
within the ER causes a wide variety of phenotypes including shortened life span, muscle atrophy,
and effects on neuronal development (40,41).
Regulation of Tissue CoA Levels
CoA Synthesis
CoA synthesis occurs through a five-step pathway involving pantothenate (vitamin B5),
ATP, and cysteine (Fig. 1.1) (1). The initial and rate-limiting step of CoA synthesis is the
phosphorylation of pantothenate to 4’-phosphopantothenate, which is catalyzed by pantothenate
kinase (PanK). There are four PanK isoforms, each sharing a common catalytic domain; however,
each isoform has a distinct N-terminal regulatory domain. The PanK1 gene encodes isoforms that
are formed through alternative splicing, creating PanK1α and PanK1β, respectively (42). The
difference between the two isoforms arises from the presence of a 184 amino acid N-terminal
extension present in the PanK1α isoform, which confers sensitivity to feed-back inhibition by CoA
(IC50 = 80 µM), acetyl-CoA (IC50 = 5 µM), malonyl-CoA (IC50 = 16 µM) and long-chain acyl-CoAs
(42,43). The activity of PanK1β, which lacks this regulatory domain, is unaffected by free and
long-chain acyl-CoAs, and this isoform is less sensitive to inhibition by acetyl- and malonyl-CoA
(IC50 = 32 µM and 140 µM, respectively), compared to PanK1α (43). PanK1 isoforms are primarily
expressed in the liver, kidneys, and heart (42).
PanK2 has been studied extensively, due to its role in neurodegeneration. In humans, the
primary difference between PANK2 and other isoforms is the presence of an N-terminal
6

mitochondrial targeting sequence that targets PANK2 to the inner-mitochondrial space (44,45).
The murine isoform lacks this targeting sequence and is cytosolic (44,45). Both the human and
murine isoforms are potently inhibited by acetyl-CoA (IC50 = 62.5 nM and 125 nM, respectively),
while being activated by palmitoyl-carnitine (44). Murine PanK2 is a major isoform in brain and
testes, and deletion results in retinal degeneration, weight loss and azoospermia (44,46). In
humans, PANK2 is the major isoform in the brain. Expression of PANK was highest in the
cerebellum, caudate nucleus and cerebral cortex (44). Mutation in human PANK2 are associated
with Pantothenate Kinase-Associated Neurodegeneration (PKAN), which is the most common
form of Neurodegeneration with Brain Iron Accumulation (NBIA) (47). While the link between
PANK2 mutations and PKAN has been firmly established, the exact mechanism through which
PANK2 causes this neurodegenerative phenotype is still being elucidated.
The final pantothenate kinase isoform, PanK3, is ubiquitously expressed (48).
Interestingly, PanK3 is 79% identical to PanK1β (48). Despite the high degree of similarity
between the two isoforms, PanK3 is 10 times more sensitive to acetyl-CoA inhibition when
compared to PanK1β and is also potently inhibited by palmitoyl-CoA (IC50 = 2 µM) (48).
Interestingly, increasing PanK3 activity in mouse models of PKAN, ameliorated the
neurodegenerative phenotype, pointing to PanK3 as an important therapeutic target (49).
Following formation by PanK, 4’-phosphopantothenate is condensed with cysteine to form
4’-phosphopantothenoylcysteine,

which

is

then

decarboxylated

to

generate

4’-

phosphopantetheine (1). These reactions take place in the cytosol and are catalyzed by 4’phosphopantothenoylcysteine

synthase

(PPCS)

and

4’-phosphopantothenoylcysteine

decarboxylase (PPCDC), respectively (Figure 1). There is a single isoform of PPCS and PPCDC
enzymes and both are ubiquitously expressed (50). The final two steps in CoA biosynthesis are
catalyzed by CoA synthase (COASY), a bifunctional enzyme that consists of a 4’phosphopantetheine adenyltransferase (PPAT) and a dephospho-CoA kinase (DPCK) domain
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(29,51). There are two known isoforms of COASY, annotated COASYα and COASYβ (52).
COASYα is a 60 kDa protein that is ubiquitously expressed. COASYβ contains a 29 amino acid
extension on the N-terminus due to alternative splicing (29,51,52). COASYβ mRNA is detectable
in the brain, kidneys, and heart; however, expression of the protein is only detectable in brain
(52). Unlike any of the previous components of the CoA biosynthetic pathway, both isoforms of
COASY localize to the mitochondria (29). COASY has been annotated to localize to both the outer
membrane and matrix of the mitochondria. Thus, determining the submitochondrial localization of
COASY will be essential for determining the location of CoA biosynthesis, and to allow for a more
complete understanding of how the cellular CoA pools are formed (30,31).
Localization of COASY to the outer mitochondrial membrane is consistent with its reported
interaction with proteins known to localize to the cytosol. COASY has been shown to interact with
enhancer of mRNA-decapping protein 4 (EDC4) (53). This interaction was shown in vitro to inhibit
the dephosphoCoA kinase activity of Coasy (53). Interestingly, removal of serum from culture
medium to simulate a condition of fasting and increased CoA biosynthesis, prevented this
interaction. Overexpression of EDC4 resulted in a 40% decrease in CoA (53). More recently,
Coasy was found to be phosphorylated by ribosomal protein S6 kinase 1 (S6K1) (54,55). While
the exact site of phosphorylation and the effect of this modification of Coasy activity have not been
directly identified, in vitro experiments suggest that this modification may inhibit the PPAT activity
of the enzyme (56).
Beyond regulation of the terminal steps in CoA biosynthesis, phosphorylation of Coasy
has been shown to promote the interaction with the p85α regulatory subunit of Phosphoinositide
3-Kinase (PI3K), promoting phosphorylation of AKT and mTOR (57,58). COASY expression in
colorectal cancer cell lines was found to be protective against radiation therapy through increased
PI3K signaling. Stable knockdown of COASY with shRNA in these cell lines reduced PI3K activity
and induced radiation sensitivity in cells lines that were previously radiation resistant (57).
8

Reduction of COASY through knockdown has also been shown to result in hyperacetylation of
cytosolic proteins through activation CREB-binding protein (CBP) (59). CBP interacts with the
PPAT domain of COASY, resulting in its inactivation and ultimately stalling mitosis and causing
multinucleation (59).
Metabolic Consequences of Supraphysiological CoA Levels
Prolonged accumulations of CoA species have been shown to underlie disease states.
For example, Leptin- deficient (Lep-/-) mice exhibit a 40% increase in total hepatic CoA levels (11).
This accumulation of (acyl-)CoA is due to a 30% increase in total PanK activity, and a coinciding
decrease in the expression of the CoA-degrading enzyme Nudt7 (11). This increase in total
hepatic CoA levels increases the rate of mitochondrial fatty acid β-oxidation. Acetyl-CoA produced
from fatty acid oxidation act as an allosteric activator of the gluconeogenic enzyme pyruvate
carboxylase, resulting in increased flux through the gluconeogenic pathway, which contributes to
hyperglycemia (11). Deletion of Pank1 in Lep-/- mice resulted in a decrease in total hepatic CoA,
which, in turn, reduced mitochondrial β-oxidation, and ameliorated the hyperglycemic phenotype
independent of insulin signaling (11). Likewise, increased CoA synthesis in skeletal muscle
through overexpression of human PANK2 led to increased oxidative stress, which resulted in
decreased complex I activity, ATP production, and exercise intolerance (60).
Metabolic Consequences of Impaired CoA Synthesis
The importance of CoA and its thioesters is underscored by the severe metabolic defects
that result from impaired CoA synthesis. Reduced hepatic CoA synthesis resulting from deletion
of Pank1, decreased the rate of mitochondrial fatty acid oxidation. Reduced NADH and acetylCoA, which are normally derived from fatty acid oxidation, decreases the flux through the
gluconeogenic pathway and caused severe fasting hypoglycemia (9). The synthesis of βhydroxybutyrate, which also depends on acetyl-CoA and NADH derived from fatty acid oxidation,
was also impaired (9). Global inhibition of CoA synthesis through treatment with Hopan, a potent
9

inhibitor of all PanK isoforms, results in the inability to oxidize fatty acids and severe fasting
hypoglycemia (12). Taken together, these data indicate that increased flux through the CoA
biosynthetic pathways is essential for the transition from the fed to fasted state. Inadequate CoA
synthesis due to PANK2 mutations underlie the dystonia, dysphagia, loss of vision and reduced
cognitive function that under lie PKAN (47). PKAN patients exhibit increased plasma lactate in
both the fasting and fed conditions, indicating a defect in mitochondrial metabolism (61).
Importantly, allosteric activation of PanK3 in a PKAN mouse model using a small molecule,
increased total CoA levels and reduced the severity of the PKAN phenotype (49).
Regulation of CoA through Degradation
In the fasted state, elevation of total tissue CoA levels is driven by increased flux through
the CoA biosynthetic pathway via allosteric activation of the PanK isoforms by long-chain
acylcarnitines, metabolites whose concentration increases in the fasted state. Upon refeeding,
feedback inhibition of PanK by CoA thioesters predominates, resulting in decreased flux through
the biosynthetic pathway. Concomitantly, active CoA degradation rapidly reduces tissue CoA
levels (12). At just 2-hours after refeeding, hepatic CoA levels decrease as much as 28% and by
4-hours after refeeding, the levels decrease by 40% (11). Mice treated with Hopan, a
pantothenate analog that inhibits all PanK isoforms, exhibit an 80% decrease in hepatic CoA
levels, which indicate rapid turnover of CoA in this organ (12). Taken together, reduction in CoA
levels occurs, not only through decreased synthesis, but also by active degradation. Intracellular
CoA-degrading enzymes have been identified in the mitochondria, peroxisomes, and lysosomes.
Within the lysosomes, CoA is dephosphoylated to dephospho-CoA (dP-CoA) likely by the
lysosomal acid phosphatase (62). The conversion of CoA to dP-CoA within the lysosomes would
occur as a part of autophagy. However, the role of this process in the regulation of CoA levels
has not been elucidated. The currently identified mitochondrial and peroxisomal CoA-degrading
enzymes belong to the Nudix hydrolase superfamily.
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Nudix Hydrolase Superfamily
Nudix hydrolases are a superfamily of pyrophosphohydrolases that perform a variety of
vital functions within the cell including hydrolysis of oxidized nucleotides, RNA de-capping,
hydrolysis of NDP-sugar conjugates and coenzymes (NAD(H), NADP(H), NMN, and CoA) (63).
Nudix enzymes are expressed throughout all domains of life including eukaryotes, prokaryotes,
archaea, and viruses (63). A 23 amino acid ‘Nudix motif’, GX5EX7REUXEEXGU (U refers to an
aliphatic, hydrophobic amino acid) is common to all members (64). The Nudix motif binds the
essential divalent cation, most commonly Mg2+ or Mn2+, which activates a water molecule to
hydrolyze the phosphosphodiester bond in the substrate (64). Substrate specificity is determined
by various binding motifs. To date, CoA-degrading Nudix hydrolases have been characterized
from Deinococcus radiodurans, Escherichia coli, Saccharomyces cerevisiae, Caenorhabditis
elegans, Arabidopsis thaliana, mice and humans (65-71). The structure of a CoA
pyrophosphohydrolase from Deinococcus radiodurans has been solved with the protein bound to
Mg2+, identifying the catalytic residues REX2EE (69). This motif is conserved throughout all known
CoA-degrading Nudix hydrolases including human and murine CoA-degrading enzymes (69).
While the crystal structure of any CoA diphosphohydrolase with CoA bound has yet to be solved,
the UPF0035 motif (LLTXRX3RX3GX3FPGG) is predicted to participate in CoA binding and is
highly conserved amongst CoA diphosphohydrolases (69). PCD1 and Y87G2A.14 are
peroxisomal CoA diphosphohydrolases characterized from Saccharomyces cerevisiae and
Caenorhabditis elegans, respectively. In vitro studies indicate that the preferred substrate for both
enzymes are CoA disulfides, and the enzymes likely function to remove these byproducts of
oxidative stress from the peroxisomal CoA pool (65,66). However, recent studies of murine Nudix
hydrolases indicate they have a much broader and complex role regarding CoA regulation.
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Murine and Human Nudix Hydrolases
In humans and mice, 22 Nudix hydrolases have been identified, two of which have been
found to be specific diphosphohydrolases that hydrolyze (acyl-)CoA into 3’,5’-ADP and acyl-4’phosphopantetheine. Nudt7 and Nudt19 are both peroxisomal CoA-degrading enzymes that are
expressed in the liver and kidneys, respectively (67,72). Both proteins contain a classic PTS1
peroxisomal targeting sequence on the C-terminus (67,72). Nudt7 is a highly promiscuous CoAdegrading enzyme that, in vitro, hydrolyzes free CoA, as well as a variety of short- and mediumchain acyl-CoAs (72,73). Nudt7 is regulated transcriptionally. In the fasted state, when CoA is
elevated, Nudt7 expression is minimal. Conversely, in the fed state, Nudt7 mRNA and protein
robustly increase, suggesting that this enzyme helps to mediate the decrease in total hepatic CoA
that is seen in the fed state (20). Overexpression of Nudt7 using a liver specific adeno-associated
virus indicates that Nudt7 functions to regulate peroxisomal CoA dependent metabolic processes.
Expression of the Nudt7 transgene resulted in a reduced rate of peroxisomal fatty acid oxidation
leading to an accumulation of long-chain acyl-carnitines and reduced hexanoyl-, butyryl-, adipoyl, and succinyl-CoA, all products of peroxisomal fatty acid oxidation (20). Interestingly, Nudt7
overexpression resulted in decreased synthesis of primary and secondary bile acids (20). While
these results have not been verified using a loss-of-function approach, this data suggests that
Nudt7 regulates the peroxisomal CoA pool and CoA dependent metabolic reactions within the
peroxisomes.
Nudt19 is another peroxisomal CoA-degrading enzyme that is expressed in the kidneys
(70). In vitro data suggests that Nudt19 degrades free CoA as well as short- and medium-chain
acyl-CoAs (72). Unlike Nudt7, Nudt19 shows very little to no activity towards acetyl-CoA. Nudt19
is also substantially larger than Nudt7 (42 kD vs. 27 kD) due to a 45-49 amino acid insertion in
the Nudix box that likely functions to assist with folding and stability of Nudt19 as deletion of this
insertion results in the protein becoming insoluble (72). While it is unclear what specific pathways
12

are effected by Nudt19 activity, deletion of Nudt19 in mice resulted in a 20% increase in total CoA
in the fed state, indicating that Nudt19 contributes to the regulation of CoA within the kidney, in
vivo (72).
Acyl-CoA Thioesterase (ACOT)-mediated CoA Regulation
Beyond removal of the 3’ phosphate group or hydrolysis of the phosphodiester bond in
the cofactor, the acyl-CoA pool can also be regulated through hydrolysis of the thioester linkage
and release of unesterified fatty acids, a reaction that is catalyzed by a family of enzymes called
acyl-CoA thioesterases (ACOTs) (74). There are two classifications of ACOTs. Type I ACOTS
belong to the α/β- hydrolase superfamily and contain a catalytic triad consisting of a serine,
histidine, and aspartic acid that are conserved throughout the α/β- hydrolase superfamily (74).
Type I ACOTS share a high degree of sequence similarity and are thought to have evolved
through gene duplication. Type II ACOTS share a low degree of sequence similarity; however
they are structurally related by containing a “hotdog” fold (74). The majority of ACOTs localize to
the mitochondria (ACOT 2,7,9,13) or the peroxisomes (ACOT 3,4,5,8,12) (75). Each ACOT has
a very specific substrate preference ranging from short-chain, dicarboxylic, medium-chain, and
long-chain acyl-CoAs. Type I ACOTs are mostly regulated transcriptionally and are targets of
PPARα. Expression is induced by fasting, high fat diet, and ketogenic diets (76). Regulation of
Type II ACOTs is less clear. Recently it was shown that mitochondrial type II ACOTs (ACOT 7,9
and 13) were all strongly inhibited by free-CoA leading to the hypothesis that activity is regulated
by the ratio of acyl-CoAs/ free CoA within the mitochondria (77).
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Objective
Coenzyme A (CoA) is an essential cofactor for a variety of metabolic pathways, most
notably, the TCA cycle, lipid biosynthesis, amino acid synthesis and degradation, as well as
fatty acid β-oxidation. CoA levels are tightly regulated. Inability to synthesize adequate levels of
CoA is associated with neurological and developmental deficits. Conversely, elevated CoA
levels in the liver are seen in the diabetic state and contribute to the hyperglycemic phenotype.
CoA levels are dynamic. They increase in the fasted state and decrease in the fed state.
Changes in the concentration of CoA species are mediated through cycles of synthesis and
degradation. While biosynthesis of CoA has been studied extensively, the means through which
this cofactor is degraded has yet to be completely elucidated. Two peroxisomal Nudix
hydrolases, Nudt7 and Nudt19, have been found to catalyze the hydrolysis of the
pyrophosphate bond of (acyl-)CoA creating (acyl-)phosphopantetheine and 3',5'-ADP. In
addition to the peroxisomes, CoA is present in the cytosol as well as the mitochondria, but
evidence for additional CoA-degrading enzymes in these subcellular compartments is missing.
Nudt8 is an uncharacterized Nudix hydrolase that has been annotated as a CoA-degrading
enzyme due to sharing 36% sequence identity to Nudt7, mainly in the catalytic region. The
primary objective of this study is to express and purify recombinant Nudt8 and determine
weather that Nudt8 is a CoA diphosphohydrolase. Nudt8 will be screened in vitro with a variety
of short- and long-chain acyl-CoAs. Additionally, using a combination of in vitro and in vivo
techniques, we will determine the mechanism regulating Nudt8 expression and activity. Finally,
to determine in vivo CoA substrates, Nudt8 will be overexpressed in the liver of C57BL/6J mice
to determine the effect of Nudt8 expression on the composition of the acyl-CoA pool in the liver.
Untargeted metabolomics will be conducted on tissue samples from these mice to elucidate any
metabolic pathways that are regulated by Nudt8 mediated CoA degradation.
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Abstract
Coenzyme A (CoA) regulates energy metabolism and exists in separate pools in the
cytosol, peroxisomes, and mitochondria. At the whole tissue level, the concentration of CoA
changes with the nutritional state by balancing synthesis and degradation; however, it is currently
unclear how individual subcellular CoA pools are regulated. Liver and kidney peroxisomes contain
Nudt7 and Nudt19, respectively, enzymes that catalyze CoA degradation. We report that Nudt8
is a novel CoA-degrading enzyme that resides in the mitochondria. Nudt8 has a distinctive
preference for manganese ions and exhibits a broader tissue distribution than Nudt7 and Nudt19.
The existence of CoA-degrading enzymes in both peroxisomes and mitochondria suggests that
degradation may be a key regulatory mechanism for modulating the intracellular CoA pools.

Introduction
CoA is an indispensable cofactor that activates acyl groups for a multitude of metabolic
reactions and the widespread posttranslational acylation of histones and other proteins (1-5).
Unacylated CoA (free CoA) has also been found to directly react with cysteine residues of target
proteins under conditions of metabolic stress, resulting in protein ‘CoAlation’ (6). CoA-dependent
metabolism and post-translational modifications occur in multiple subcellular compartments,
including the nucleus and the endoplasmic reticulum, but the cytosol, peroxisomes, and
mitochondria contain the major pools of this cofactor (5,7-9). The mitochondria are estimated to
contain the highest concentration of CoA (7,8,10), which is required to activate gluconeogenesis
and for pathways such as ketogenesis, fatty acid oxidation, and the TCA cycle.
At the whole tissue level, the concentration of CoA changes with the metabolic state by
coordinating synthesis and degradation. In the liver, activation of the biosynthetic pathway drives
the increase in CoA that occurs in the transition between the fed and fasted state (11,12).
Conversely, the net decrease in the concentration of hepatic CoA observed upon refeeding after
a fast requires both inhibition of de novo CoA synthesis and degradation of the cofactor
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accumulated in the fasted state. At the subcellular level, such metabolic adaptations require
modulation of the size and composition of the individual CoA pools (7,8). To date, however, our
knowledge of the mechanisms regulating these subcellular CoA pools is limited.
In the peroxisomes of liver and kidneys, CoA is hydrolyzed to 3’,5’-ADP and (acyl)phosphopantetheine by two Nudix hydrolases, Nudt7 and Nudt19, respectively (13-16). Unlike
intact CoA, these smaller degradation products can exit the peroxisomes (17); thus, the activity
of Nudt7 and Nudt19 likely plays an important role in the regulation of the peroxisomal CoA pool
and, in turn, CoA-dependent peroxisomal metabolism (12,17,18). Consistent with such a role, the
expression of Nudt7 and the activity of Nudt19 are higher in the fed state compared to the fasted
state, and inversely correlate with tissue CoA levels in the liver and kidneys, respectively
(13,16,19).
Nudix hydrolases hydrolyze phosphodiester bonds in a variety of substrates including
nucleoside di- and triphosphates, dinucleoside polyphosphates, nucleotide sugars and cofactors
like CoA and NAD(P)H (20,21). All Nudix hydrolases are characterized by the presence of the
Nudix box motif, G[5X]E[7X]REXXEEXGU (where U is a hydrophobic residue and X is any
residue), which coordinates a catalytically essential divalent cation (22,23). Nudix hydrolases that
specifically

hydrolyze

CoA

contain

another

conserved

motif,

(L/M)(L/F)TXR(S/A)[3X](R/K)[3X]G[3X]FPGG (PROSITE accession number PS01293), called the
CoA box, which contains residues important for CoA binding and catalysis (13,24). In addition to
mammals, peroxisomal Nudix hydrolases specific for CoA are present in yeast and nematodes
(24,25). Plants contain cytosolic and mitochondrial isoforms (26); however, no mammalian
counterparts have been identified so far.
Nudt8 is an uncharacterized Nudix hydrolase that has been annotated as a mitochondrial
enzyme and is closely related to Nudt7 (21,27). In this study, we show that Nudt8 specifically
hydrolyzes CoA, is indeed a mitochondrial enzyme, and is broadly expressed in mitochondria-rich
organs such as the heart, kidneys, liver, and brown adipose tissue. The characterization of the
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first mitochondrial CoA-degrading enzyme in mammals provides a potential mechanism for the
dynamic regulation of the mitochondrial CoA pool.

Materials and Methods

Materials
Reagents were purchased from the following suppliers: oligonucleotides, Lipofectamine
2000, cell culture reagents, Alexa Fluor 647- and HRP-conjugated goat anti-rabbit IgG, and
MitoTracker Orange CMTMRos from Thermo Fisher Scientific; restriction enzymes from New
England Biolabs; HEK293 and HEK293T cells from the American Type Culture Collection; Swift
membrane

stain

from

G-biosciences.

Antibodies

against

glyceraldehyde-3-phosphate

dehydrogenase (GAPDH), citrate synthase, and catalase were purchased from Cell Signaling.
The Nudt7 antibody was generated as previously described (19). 3’,5’-ADP and antibodies
against ATP-binding cassette, sub-family D, member 3 (PMP70) and the FLAG epitope were
obtained from Sigma-Aldrich; the Dylight 488 mouse IgG was purchased from Rockland
Immunochemicals. The antibody against the full-length mouse Nudt8 was raised in rabbit and
purified by antigen affinity chromatography. The fluorescent CoA derivative of monobromobimane
(mBB), mBB-CoA, was synthesized as previously described (13). All other reagents were of
analytical grade or better and were purchased from Sigma-Aldrich or Fisher Scientific, unless
otherwise stated.

Nudt8 purification and enzymatic assays
Mouse Nudt8 (accession NP_079805.1) was expressed as a C-terminal hexahistinetagged protein from the pET21-derived plasmid pKM202, a kind gift of Suzanne Jackowski at St.
Jude Children's Research Hospital. Nudt8 was expressed in E.coli BL21 Codon Plus (DE3)-RIPL
cultured in auto-inducing medium for 24 h at room temperature (28). The enzyme was purified by
Ni-NTA chromatography, followed by dialysis in 20 mM Tris-HCl, pH 8.5, 1 mM EDTA, 1 mM DTT
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at 4 C overnight. The combined dialyzed fractions were applied onto a POROS 50 HQ column
(Thermo Fisher Scientific). Nudt8 was eluted in two peaks at 160 and 305 mM NaCl in 40 mM
diethanolamine hydrochloride, pH 9.0. Only the peak eluted at 160 mM NaCl contained enzymatic
activity. Active fractions containing >80% pure Nudt8 were combined and concentrated to >1
mg/ml. Glycerol was added to a final concentration of 50% before storing the protein at -20 C.
For the analysis of Nudt8 by analytical gel filtration, purified recombinant Nudt8 (50 μl) was loaded
onto a Superdex 75 10/300 GL column and eluted at 0.3 ml/min with 50 mM Tris-HCl, 150 mm
NaCl, 1 mM DTT, 1 mM EDTA, pH 8.5. Protein elution was monitored by measuring the
absorbance at 280 nm. The activity of Nudt8 was assayed as previously described (13). The
optimized standard assay mixture contained 50 ng of enzyme, 100 mM Tris-HCl pH 8.5, 0.1 mg/ml
γ-globulin, 250 µM of free CoA or acyl-CoA substrates and 2 mM MnCl2, in a total volume of 40
µl. Kinetic parameters were determined by varying the substrate concentration from 0.125 to 4
mM. Data points, individually corrected for the background in reaction mixtures lacking the
enzyme, were fitted to a ‘Specific Binding with Hill slope’ and ‘kcat’ models using Graphpad Prism
6 (GraphPad Software) to determine the kinetic parameters.

Animal studies
C57BL/6J male mice were purchased from the Jackson Laboratory and allowed to
acclimate for at least 7 days. The mice were fed a standard chow diet (Tekland 2018S) and
maintained at a room temperature of 22.2  0.2 C, room humidity of 40%  2%, and a 12-h light,
12-h dark cycle, with the dark cycle starting at 6:00 pm. For fasting experiments, the mice were
placed on cages with grids for 24 h without food. All studies were approved by the Institutional
Animal Care and Use Committees of West Virginia University.

Subcellular fractionation
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All centrifugation steps were conducted at 4 °C. To obtain mitochondria-free peroxisomal
fractions, we pooled the livers from two mice and adapted the procedure described by
Antonenkov, V. D. et. al. (29). Briefly, the combined livers were weighed, minced, and
homogenized in 4 volumes of peroxisomal homogenization medium (0.16 M sucrose, 12%
PEG1500, 10 mM MOPS pH 7.4, 1 mM EDTA, 1 mM EGTA, 0.1% ethanol, 0.1 mM PMSF, 2 mM
DTT) using 5-6 strokes of a motor-driven Teflon pestle at a speed of 550 rpm. The homogenate
was centrifuged at 1,500 x g for 12 min, and the supernatant was applied onto a 50% Percoll
cushion. After centrifuging at 23,500 x g for 1 h, the peroxisomal fraction was removed from the
bottom of the cushion, diluted with 1 ml of homogenization medium, and applied onto an Optiprep
density gradient. The gradient was centrifuged at 68,000 x g in a 70.1 Ti fixed angle rotor for 1 h.
Fractions (1 ml) were removed starting from the bottom of the Optiprep gradient and stored at 80 °C until analyzed.

Immunoblotting, RT-PCR and immunofluorescence
For western blot analysis, subcellular fractions and tissue homogenates were fractionated
by SDS-PAGE on 4-12% Bis-Tris gels and transferred onto PVDF membranes. Flash frozen
tissues were homogenized in ice-cold radioimmunoprecipitation assay buffer containing protease
inhibitors and centrifuged at 10,000 x g for 10 min at 4°C. To normalize antibody signals to total
protein loaded, membranes were stained with Swift membrane stain as per manufacturer’s
instructions. Antibodies were used at the following dilutions: Nudt8, Nudt7 and GAPDH antibodies
at 1:3,000; citrate synthase, catalase and FLAG antibodies at 1:1,000. Primary antibodies were
detected by chemiluminescence with HRP-conjugated goat anti-rabbit or goat anti-mouse IgG at
1:45,000 dilution. Western blot bands were quantified using Genetools (Syngene) or ImageJ
analysis software.
RNA was isolated from flash frozen tissue as previously described (13,30). Nudt8 mRNA
levels were quantified in triplicate by RT-PCR using the Quantitect SYBR Green RT-PCR kit
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(Qiagen)

and

the

primers

5'-CAGTTTCCCAGGCGGTAAGT-3'

and

5'-

CACGTTGGCAAGTACTGGGA-3' as the forward and reverse primers, respectively. Primers for
Nudt7 and Nudt19 have been published (30). For each tissue, the relative abundance of Nudt7,
Nudt8, and Nudt19 mRNA was calculated by the CT method using the averaged CT values for
two calibrators, ribosomal protein L22 (Rpl22) and β2-microglobulin (B2m). Primers 5’GTGCCTTTCTCCAAAAGGTATTT-3’ and 5’-CTCTCTTTGCTGTTGGCGAC-3’ were used as
forward and reverse primers, respectively, for Rpl22. Primers 5’-ACTGACCGGCCTGTATGCTA3’ and 5’-ATGTTCGGCTTCCCATTCTCC-3’ were used as forward and reverse primers,
respectively for B2m.
To express Nudt8 in mammalian cells, Nudt8 was amplified from pKM202 using primers
introducing an EcoRI restriction site and a Kozak sequence at the 5' end and a FLAG tag and an
XhoI restriction site at the 3' end. The amplified product was subcloned into pcDNA3.1(+) (Thermo
Fisher Scientific) between EcoRI and XhoI sites. HEK293 and HEK293T cells were cultured and
transfected as previously described (13). The localization of mouse Nudt8 in HEK293 cells was
determined by confocal microscopy, as previously reported (13). The FLAG antibody was used
at a 1:1,000 dilution and incubated overnight. Dylight 488 goat anti-mouse IgG was used at a
1:5,000 dilution.

Statistical Analysis
Unless otherwise stated, all data are reported as the mean ± standard error. Statistical
significance was calculated by unpaired two-tailed Student's t test using GraphPad Prism 6
(GraphPad Software).
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Results

Nudt8 specifically hydrolyzes CoA species and has a distinctive preference for manganese
ions
Mouse Nudt8 shares a 38% sequence identity with the CoA-degrading enzyme Nudt7 (Fig
2.1A). Both proteins contain the CoA and Nudix boxes and the sequence identity in these regions
increases to 60%. To test the
possibility

that

Nudt8

could

hydrolyze

CoA

species,

we

expressed
and purified the mouse enzyme as
a 24 kDa protein with a C-terminal
hexahistidine

tag

(Fig.

2.1B).

Compared to recombinant Nudt7,
Nudt8 was purified in significantly
lower amounts. Indeed, one liter of
auto-induced

culture

typically

yielded about 15 mg of Nudt8
compared to the 70-100 mg of
Nudt7

obtained

per

liter

of

standard E. coli culture (13).
Interestingly, we also attempted
to

express

human

NUDT8;

however, similar to a report by
Carreras-Puigvert et al., we could
not detect any expression (21).

Figure 2.1 Expression and characterization of mouse Nudt8. (A)
Alignment of the protein sequences of mouse and human Nudt8 and
Nudt7. Invariant residues are highlighted in red, conserved residues in
yellow, and groups of conserved residues are boxed. The Nudix box (blue
stars) and the CoA box (pink circles) overlap at a glycine highlighted in
black. Mm, Mus musculus; Hs, Homo sapiens; Genbank GI numbers for
the aligned proteins are: MmNudt8, 13384950; HsNUDT8, 344217763;
MmNudt7, 165972342; HsNUDT7, 157785656. Sequence alignments
were obtained using ESPript 3 (1). (B) Coomassie blue-stained protein gel
showing purified Nudt8. M, molecular weight marker. (C) Elution profile of
purified, His-tagged Nudt8 from a Superdex 75 10/300 GL column. The
inset shows the calibration curve used to estimate the apparent molecular
weight of Nudt8. The calculated molecular weight of the recombinant
protein, based on the amino acid composition, is 24.3 kDa. (D) Highperformance liquid chromatography (HPLC) elution profile of the
degradation product co-migrating with a 3’,5’-ADP standard formed in
reaction mixtures containing Nudt8 and free CoA. * marks a solvent
impurity.

Analytical gel filtration analysis of
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recombinant mouse Nudt8 indicated that similar to Nudt7 (13), about 70% of the protein eluted
as a monomer (Fig. 2.1C).
We next tested the hydrolytic activity of Nudt8 in the presence of 4 mM MgCl2 a nd a broad
range of Nudix hydrolase substrates including ATP, ADP, NAD+, NADH, NADP+, NADPH,
diadenosine triphosphate, ADP-ribose and free CoA. Product formation was detected only with
free CoA as a substrate and co-elution of this product with a 3',5'-ADP standard confirmed that
Nudt8 was a CoA diphosphohydrolase (Fig. 2.1D). Under the assay conditions used for Nudt7
(13), the specific activity of Nudt8 was about 100-fold lower (Fig. 2.2B), suggesting that one or
more components of the reaction mixture needed to be optimized for Nudt8. Raising the buffer
pH from 8.0 to 8.5 modestly increased Nudt8 activity; however, substituting Mg2+ with Mn2+ as the
catalytically essential divalent cation in the reaction mixture, increased free CoA hydrolysis from
about 2% to over 90% (Fig. 2.1A).

Figure 2.2. Divalent cation requirement and substrate specificity of recombinant Nudt8. (A)
The ability of different divalent cations to support the hydrolytic activity of Nudt8 was tested in
reaction mixtures containing 6 µg of Nudt8, 250 µM of free CoA and 0.5 mM of each cation
introduced as the chloride salt. (B) Nudt8 and Nudt7 protein curves in the presence of the indicated
concentrations of MgCl2 and MnCl2. Linear regression of the curves, obtained using 3
independently purified Nudt8 batches in duplicate, was used to calculate the specific activity of the
enzymes  standard error. In the presence of the optimal concentration of MnCl 2, the specific
activity of Nudt8 (2.4 ± 0.1 pmoles/min/ng of protein) was comparable to the specific activity of
Nudt7 with either MgCl2 (3.0 ± 0.1 pmoles/min/ng of protein) or MnCl2 (2.8 ± 0.1 pmles/min/ng of
protein). (C) CoA diphosphohydrolase activity of Nudt8 against multiple CoA substrates. Data in
panels A and C are plotted as the mean (bars) of experiments conducted in duplicate using 3
independently purified Nudt8 batches (circles) ± SEM.
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The optimal concentration of MnCl2 was found to be 2 mM (data not shown). Under these
optimized conditions, the specific activity of Nudt8 against free CoA was comparable to that of
Nudt7 with either MgCl2 or MnCl2 (Fig. 2.2B). Importantly, we re-screened the diphosphatecontaining molecules above as potential Nudt8 substrates in the presence of 2 mM MnCl2 and
confirmed that the activity of the enzyme remained specific for free CoA (data not shown).
Having established that Nudt8 was a CoA diphosphohydrolase, we measured its activity
Substrate

KM, µM

kcat, min-1

kcat/KM, min-1*µM-1

Free CoA

150 ± 13

216 ± 8

1.44

Acetyl-CoA

707 ± 252

116 ± 10

0.16

Propionyl-CoA

318 ± 87

155 ± 14

0.49

lauroyl- and stearoyl-CoA, as these

Butyryl-CoA

224 ± 40

107 ± 9

0.48

compounds precipitated even at the

Malonyl-CoA

233 ± 71

184 ± 19

0.79

Succinyl-CoA

329 ± 72

187 ± 14

0.57

Hexanoyl-CoA

251 ± 98

149 ± 11

0.59

against various short- and mediumchain acyl-CoAs. We could not test
long-chain acyl-CoAs, such as

lowest

concentration

of

MnCl2

required to detect Nudt8 activity.
Nudt8 hydrolyzed all CoA species
tested, exhibiting the highest activity
toward free CoA, hexanoyl- and

Table 2.1. Kinetic Parameters of Nudt8. KM, kcat and
specificity constant (kcat/KM) for Nudt8 with different CoA
substrates. The kinetic parameters KM and kcat were
determined, ± SEM, by non-linear regression analysis of data
obtained from 3 independent experiments, each conducted in
duplicate.

octanoyl-CoA and the lowest activity against acetyl-CoA (Fig. 2.2 C). Nudt8 also readily
hydrolyzed the synthetic CoA derivative mBB-CoA.

Analysis of Nudt8 kinetics toward

representative acyl-CoAs revealed KMs ranging from 150 µM for free CoA to 707 µM for acetylCoA (Table 2.1). The values were in the same range of KMs reported for Nudt7 and Nudt19 (1416). Taking both the kcat and the KM into consideration, the specificity constants calculated for the
substrates confirmed that free CoA and acetyl-CoA were the best and worst substrates for Nudt8,
respectively (Table 2.1).
Combined, these data indicated that Nudt8 is a novel CoA diphosphohydrolase with broad
acyl-CoA substrate specificity and a distinctive preference for Mn2+, a feature not observed in the
other known mammalian isoforms, Nudt7 and Nudt19 (14,15).
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Figure 2.3. Relative abundance and tissue distribution of Nudt8 mRNA and
protein. (A) Relative abundance of mouse Nudt8, Nudt7, and Nudt19 transcripts in
selected tissues. Data are reported as the mean (bars) of measurements on individual
mice (circles) ± SEM. (B-D) HEK293T cells were transfected with either an empty
plasmid or plasmids carrying the coding sequences for the FLAG-tagged versions of
Nudt8, Nudt7, and Nudt19. Representative western blots showing that (B) the Nudt8
antibody did not cross-react with Nudt7 or Nudt19, while (C) the FLAG antibody
detected all isoforms. (D) Quantification of the Nudt8 and FLAG signals from 3
independent transfections (circles)  SEM. (E) Levels of Nudt8 protein in mouse
tissues as quantified by western blot analysis. Data are reported as the mean (bars)
of measurements of the Nudt8 signal in tissues from individual mice (circles) ± SEM.
Inset, representative western blot. Abbreviations: Sk. Muscle or Sk. M., skeletal
muscle; BAT, brown adipose tissue; WAT, white adipose tissue. GAPDH was used to
normalize the Nudt8 and FLAG signals in (B) and (C) and to normalize the tissue
Nudt8 signal in (E).

Nudt8 exhibits a broad tissue distribution and its expression does not change with the
nutritional state
Nudt7 and Nudt19 exhibit a very narrow tissue distribution, predominating in the liver and
kidneys, respectively (13,15,16). To determine the tissue distribution and relative transcript
abundance of Nudt8 with respect to Nudt7 and Nudt19, we measured the mRNA levels of all three
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enzymes in different organs. We found that Nudt8 was the major isoform in the heart, brain, and
skeletal muscle. Furthermore, Nudt8 mRNA in the kidneys was as abundant as Nudt19 mRNA
(Fig. 2.3A). We next generated a polyclonal antibody to measure Nudt8 protein expression in
each tissue. To determine the isoform specificity of the Nudt8 antibody, we analyzed lysates from
HEK293T cells transfected with constructs encoding FLAG-tagged versions of Nudt8, Nudt7, and
Nudt19, or the empty vector. While the FLAG antibody detected all three enzymes (Fig. 2.3C),
the Nudt8 antibody recognized only Nudt8 (Fig. 2.3B), indicating isoform specificity. Western blot

Figure 2.4. Nudt8 expression in the liver, kidneys and heart of fed and fasted
mice. (A) Nudt8 mRNA in the liver, kidneys and heart of mice fed ad libitum or fasted
for 24 h. (B) Western blot analysis showing that Nudt8 protein levels do not change
with the nutritional state. Total protein loading is shown under each immunoblot. (C)
Quantification of the western blots in (B) normalizing to total protein loading and
expressing the corrected intensity relative to the fed state. Data in (A) and (C) are
shown as the mean (bars) of measurements on individual mice (circles) ± SEM.

analysis of different tissues showed that Nudt8 was expressed at the highest levels in the kidneys,
heart, brown adipose tissue, and liver (Fig. 2.3E). Detectable, but significantly lower levels of the
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enzyme were also found in the brain, skeletal muscle, and white adipose tissue. Combined, these
data indicated that Nudt8 had a much broader tissue distribution than Nudt7 and Nudt19.
Nudt7 is regulated by the nutritional state and its mRNA and protein levels in the liver
decrease with fasting (16,19). Conversely, the expression of Nudt19 in the kidneys remains
constant between the fed and fasted states, despite the contribution of Nudt19 to the regulation
of the concentration of CoA in the fed state (13). We quantified Nudt8 mRNA and protein levels
in the liver, kidneys and heart of mice fed ad libitum or fasted for 24 h. Similar to Nudt19, but
unlike the closely related Nudt7, Nudt8 expression did not change with the nutritional state in any
of the tissue analyzed (Fig. 2.4), suggesting that regulation might occur through a different
mechanism.

Mitochondrial localization of Nudt8
Many eukaryotic CoA diphosphohydrolases, including Nudt7 and Nudt19, localize to the
peroxisomes. Nudt8 does not contain a peroxisomal targeting signal; instead, its N-terminus
contains a putative mitochondrial targeting sequence within the first 24 residues, as predicted by
both TargetP (31) and MitoFates (32). Furthermore, Nudt8 is annotated as a mitochondrial
protein in the Mitocarta 2.0 database, an inventory of mouse and human proteins whose
mitochondrial localization is supported by a combination of computational and proteomics data
(27). To verify the subcellular localization of Nudt8 in intact cells, HEK293 cells were transiently
transfected with a construct expressing Nudt8 with a C-terminal FLAG tag. Using the FLAG tag
antibody, we found that Nudt8 co-localized with the mitochondrial marker MitoTracker Orange
CMTMRos, but not with the peroxisomal marker PMP70 (Fig. 2.5A-F). To corroborate this
conclusion in mouse tissue, we fractionated liver homogenates with a protocol that achieved some
degree of separation between peroxisomes and mitochondria (Fig. 2.5G-H). While endogenous
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Figure 2.5. Mitochondrial localization of Nudt8. HEK293 cells were transfected with
plasmids encoding Nudt8 with a C-terminal FLAG tag, fixed, and analyzed by confocal
microscopy. (A, C, D, F) Nudt8, visualized with the FLAG antibody, is in green. (B-C)
Mitochondria, visualized using Mitotracker Orange CMTMRos, are in red. (E-F) Endogenous
PMP70, used as a peroxisomal marker, is in red. Cell nuclei were stained with DAPI, in blue.
Insets in merged images show details at higher magnification. The results are representative
of at least 2 independent experiments. (G-H) Subcellular fractionation of mouse livers. Nudt8
exhibited a sedimentation profile similar to the mitochondrial marker citrate synthase. Catalase
and Nudt7 were used as peroxisomal markers. The results are representative of 4 independent
experiments quantified in (H) relative to the input in the Percoll layer, P. H, liver homogenate;
F1-8, fractions 1-8.

Nudt8 was found in mitochondria-enriched fractions (Fig. 2.5G-H, fractions F5-F6), exhibiting the
same fractionation profile as the mitochondrial marker citrate synthase, this enzyme was not
detected in fractions containing purified peroxisomes (Fig. 2.5G-H, fractions F2-F4), as marked
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by both catalase and Nudt7. Combined, these results supported the conclusion that Nudt8
localized exclusively to the mitochondria.

Discussion
Until now, only liver and kidney peroxisomes were known to contain enzymes capable of
degrading CoA (14,15). The major finding of this work is that Nudt8 is a novel CoA
diphosphohydrolase that localizes to the mitochondria and has a broad tissue distribution. Thus,
our data strongly suggest that regulation of CoA levels by degradation occurs in more organs than
previously thought and in both peroxisomes and mitochondria.
Recombinant mouse Nudt8 readily hydrolyzed free CoA and a variety of short-chain acylCoAs but exhibited a relatively low activity against acetyl-CoA (Fig. 2.2C and Table 2.1).
Additionally, this enzyme showed a distinctive preference for Mn2+ ions that sets it apart from the
peroxisomal isoforms Nudt7 and Nudt19, which can use Mg2+ or Mn2+ (Fig. 2.2B) (14,15). Given
some of the properties of Mn2+, this strong metal preference could potentially play a role in the
substrate specificity of Nudt8 and, in particular, in the low binding affinity that the enzyme showed
towards acetyl-CoA compared to the closely related Nudt7 (16). Indeed, Mn2+-ligand bonds are
more flexible than the equivalent Mg2+-ligand bonds both in length and angle. Furthermore, Mn2+
binds nitrogen-containing ligands (e.g. histidines) more frequently than Mg2+ and can form
bidentate complexes with aspartate and glutamate residues (33,34).

In the case of Nudix

hydrolases the latter property may be particularly relevant given that the Nudix box motif
G[5X]E[7X]REXXEEXGU contains three invariant glutamates (underscored) that play a key role
in the coordination of the catalytically essential metal ion. While this motif is highly conserved
between Nudt7 and Nudt8, the binding of Mn2+ may impart a unique geometry to the Nudt8 active
site and affect substrate binding. Crystal structures of Nudt7 and Nudt8 with substrate and
preferred metal bound will be required to determine whether the presence of Mn2+ can explain
how Nudt8 better discriminates between acetyl-CoA and other CoA substrates compared to
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Nudt7. This substrate specificity, in turn, may be relevant to the physiological function of Nudt8.
Under our assay conditions, the optimal MnCl2 concentration for Nudt8 was 2 mM, which is within
the physiological range of the estimated Mn2+ concentration inside the mitochondria (35,36).
Interestingly, significant activation by Mn2+ has also been observed for other mitochondrial Nudix
hydrolases including mouse Nudt13, an enzyme that degrades NADP(H), and AtNudt15, a CoA
diphosphohydrolase in A. thaliana that, however, was not tested against acetyl-CoA (37,38).
Importantly, the existence of Nudt8 and its CoA-degrading activity may explain how, even in the
absence of Nudt19 and any detectable levels of Nudt7, the concentration of CoA could still be
significantly decreased in the kidneys of Nudt19-/- mice during the transition from the fasted to the
fed state (13).
Nudt8 was highly expressed in all the mitochondria-rich organs analyzed except the
skeletal muscle (Fig. 2.3A). This is not unusual, as different organs contain variable levels of
mitochondrial proteins depending on the functional emphasis of their mitochondria (39,40).
Interestingly, the expression of Nudt8 closely correlated with the concentration of CoA in those
organs (41), and the expression of Nudt8 in skeletal muscle, which contain a relatively small CoA
pool, may be proportionally adjusted to the concentration of the cofactor to avoid depleting it. At
the subcellular level, mitochondria contain the highest concentration of cellular CoA (7,8) and are
the site of several CoA-dependent metabolic processes, including glucose and fatty acid
oxidation. CoA is present in both the mitochondrial matrix and the intermembrane space. While
the localization of Nudt8 places it in a position to modulate mitochondrial metabolism, the precise
physiological role of this enzyme will depend on the submitochondrial CoA pool that it can actually
access. Using independent spatially restricted enzyme tagging-based approaches, two studies
have recently identified human NUDT8 as a resident of the inner membrane/matrix in HEK293T
cells (42,43), which suggests that Nudt8 may regulate the matrix CoA pool. Such localization
would also potentially place Nudt8 in the same compartment as CoA synthase (Coasy), the last
enzyme in the CoA biosynthetic pathway (44-46). Coasy catalyzes the formation of dephospho35

CoA from ATP and phosphopantetheine and the final phosphorylation of dephospho-CoA to CoA.
Coasy has been localized to both the outer mitochondrial membrane (46) and the inner
membrane/matrix (42). In the absence of regulatory mechanisms, the latter subcellular
localization would allow Coasy to re-synthesize CoA from the phosphopantetheine produced by
Nudt8, generating wasteful cycles of CoA synthesis and degradation. Our data indicate that in the
kidneys, heart and liver, organs with high expression of Nudt8 and detectable CoA-degrading
activity (13,47,48), Nudt8 levels did not change with the nutritional state. Additional studies will
be required to determine whether other potential regulatory mechanisms, including
posttranslational modifications or regulation by metabolites in the mitochondria, may control the
activity of Nudt8 and whether Coasy and Nudt8 actually localize to the same sub-mitochondrial
compartment.
In conclusion, the identification and characterization of Nudt8 as a mitochondrial CoAdegrading enzyme indicates that CoA degradation is not limited to the peroxisomes and may
provide a common mechanism to regulate the subcellular pools of CoA in response to changes
in the metabolic state.
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Chapter III: Effect of liver specific overexpression of Nudt8 on mitochondrial metabolism

Abstract
Coenzyme A (CoA) is an essential cofactor that drives a multitude of metabolic reactions
within the cell. There are three pools of CoA located in the mitochondria, peroxisomes, and cytosol
that support metabolic processes specific to those organelles. In the fasted state, increased CoA
biosynthesis drives fatty acid oxidation, gluconeogenesis and ketogenesis in the liver. Upon
refeeding, CoA levels are rapidly decreased as a result of decreased synthesis and active
degradation. Recently, Nudt8 was found to be a CoA-degrading enzyme that localizes to the
mitochondria. In the liver, approximately 80% of (acyl-)CoA is in the mitochondrial matrix, thus
Nudt8 is positioned to regulate the largest pool of (acyl-)CoAs in the cell. To gain insight into the
role of Nudt8 in the regulation of the mitochondrial acyl-CoA pool, this protein was overexpressed
using a liver-specific adeno-associated virus (AAV). An AAV carrying GFP was used as a control.
Overexpression of Nudt8 did not affect total CoA levels in the mitochondria or cytosolic fractions.
Furthermore, analysis of changes to individual CoA species by LC/MS/MS showed no major
changes to the composition of the acyl-CoA pool. Despite a 1.5-fold increase in CoA-degrading
activity in the livers of the Nudt8-AAV mice, this did not translate into alterations in CoA
metabolism. One possible explanation is that CoA biosynthesis likely compensated for the
increase in Nudt8-mediated degradation in order to maintain the mitochondrial CoA pool.

40

Introduction
Coenzyme A (CoA) is an integral cofactor that forms a thioester bond with carboxylic acids
to form acyl-CoA thioesters (1). Hydrolysis of this thioester bond is energetically favorable
allowing CoA to act as an acyl-donor that drives a multitude of metabolic reactions including fatty
acid synthesis and oxidation, ketone synthesis and oxidation, tricarboxylic acid cycle, and
acetylcholine synthesis (2,3). Additionally, (acyl-)CoAs can act as acyl-donors to posttranslationally modify proteins, effecting gene expression, protein stability and subcellular
localization (4-6). Through allosteric regulation, CoA and (acyl-)CoAs can directly regulate flux
through metabolic pathways (3). Recently, it was shown that in conditions of metabolic stress, the
thiol of CoA can directly react with cysteines of target proteins resulting in ‘CoAlation’ (7,8).
CoA levels are tightly regulated through cycles of synthesis and degradation (9). In the
fasted state, accumulation of long-chain acyl-carnitines activate CoA biosynthesis through the
allosteric activation of the initial and rate-limiting enzyme Pantothenate kinase (PanK) (10) . The
increase in free CoA that occurs in the fasted state directs cellular metabolism towards processes
like fatty acid β-oxidation, ketogenesis and increased flux through the gluconeogenic pathway in
the liver (10) . Upon refeeding, a rapid decrease in CoA levels shifts metabolism away from fatty
acid oxidation and promotes glucose oxidation and lipogenesis (10,11). This net decrease in CoA
levels occurs through inhibition of biosynthesis and active degradation (12). The importance of
this tight regulation of CoA levels is underscored as prolonged elevations in total CoA through
transgenic expression of PANK2 resulted in decreased ATP production, decreased Complex I
activity, and increased reactive oxygen species (13). Further, the Lep-/- mouse model was found
to have increased total hepatic CoA levels that drive fatty acid oxidation and gluconeogenesis
that contributes to the hyperglycemic phenotype (11). Importantly, reduction in (acyl-)CoA levels
corrects the diabetic phenotype independent of insulin signaling (11).
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To date, the only known CoA-degrading enzymes belong to the Nudix hydrolase
superfamily. CoA-degrading Nudix enzymes hydrolyze (acyl-)CoAs creating 3’,5’-ADP and an
(acyl-)phosphopantetheine (9). Nudt7 and Nudt19 are peroxisomal CoA-degrading enzymes that
are expressed in the liver and kidneys respectively (14-17). While we don’t have a complete
understanding of the role of Nudt7 and Nudt19 on CoA regulation, it is likely confined to the
peroxisomal CoA pool, as deletion of these proteins does not prevent the decrease in total CoA
that is associated with the transition from fasted to fed nutritional states (16). Recently, Nudt8 was
identified as a novel CoA-degrading enzyme that has a wide tissue distribution and localizes to
the mitochondria (18). In the liver, the mitochondria contain approximately 80% of the cellular
(acyl-)CoAs, thus the broad tissue distribution of Nudt8 coupled with its prescence in the
mitochondria indicate it could be an important regulator of (acyl-)CoA (9).
The mitochondrial matrix contains of the highest concentration of CoA within the cell. The
mitochondrial inner membrane is impermeable to CoA, which is thought to be imported into the
matrix by Solute carrier proteins; however, this has not been confirmed in vivo (19-21). To gain
insight into the role of Nudt8 and its ability to regulate the mitochondrial (acyl-)CoA pool, we first
determined its submitochondrial localization. Using a protease protection assay in conjunction
with proximity tagging we were able to show that Nudt8 localizes to the mitochondrial matrix. To
gain insight into in vivo substrates of Nudt8 we overexpressed it in the liver of C57Bl/6J mice
using a liver-specific AAV mediated expression. Despite robust overexpression of the transgene,
Nudt8 had no effect on the total CoA levels in the mitochondria. Additionally, we examined
changes on free CoA and individual acyl-CoA species via mass spectrometry and found that the
transgene did not have a significant effect on the composition of the acyl-CoA pool, as only a few
acyl-CoA species were significantly altered. Taken together, our data indicates that despite
increase in (acyl-)CoA degradation in the liver, CoA biosynthesis likely compensated for this
effect.
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Materials and Methods
Reagents were purchased from the following suppliers: oligonucleotides, Lipofectamine 2000,
cell culture reagents, HRP-conjugated goat anti-rabbit IgG, MitoTracker Red CMXRos, and HRPStreptavidin from ThermoFisher Scientific; restriction enzymes from New England Biolabs; NIH3T3 cells from the American Type Culture Collection. The Mito-V5-APEX plasmid was obtained
from Addgene (#72480). The Dylight 488 conjugated goat anti- mouse secondary from Rockland
Antibodies and Assays. The antibodies against the FLAG epitope and alpha tubulin were obtained
from Sigma-Aldrich. The citrate synthase and cytochrome C antibodies from Abcam. The antibody
against the full-length mouse Nudt8 was generated as previously described (18). mBB-CoA was
synthesized as previously described (22). The 3’,5’-ADP used as standard for the product of the
Nudt8 reaction was purchased from Sigma-Aldrich. All other reagents were of analytical grade
or better and were purchased from Sigma-Aldrich or Fisher Scientific, unless otherwise stated.
Adeno-Associated Virus production
Plasmid pscAAV-LP1, carrying the green fluorescent protein coding sequence (GFP), was
developed by John T. Gray and provided by St. Jude’s Children’s Hospital, Memphis, TN.
Generation of the psc-AAV-LP1-mNudt8 was performed as follows: Nudt8 in pET28A was excised
with Nde1 and Not1 and ligated it into the psc-AAV-LP1. AAV was produced as described in (16).
Animal Studies
Six week- old C57BL/6J male mice were purchased from Jackson Laboratory. Mice were
fed a standard chow diet (Tekland 2018S) and were housed in a room that was maintained at a
standard temperature of 72.0°F, 40% ± 2%. Animals were exposed to 12-hour light/ dark cycles,
with the dark cycle beginning at 18:00 h. Following a 2-week acclimation period, mice were
injected, via tail vein, with 2.5 *1011 genome copies of the GFP- or Nudt8-AAV in PBS (150 µl).
Fasting experiments were started at 7:00 am, with mice being removed from cages and placed
into cages with grids without food for 24-hours, unless otherwise noted. Blood glucose
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measurements were obtained via tail bleeding using a glucometer. Both fed and 24 hour fasted
measurements were done at 7:00 am. Measurement of β- hydroxybutyrate was performed on
serum obtained from cardiac puncture and stored at -80°C prior to analysis. Serum was analyzed
using colorimetric assay kit from Cayman Chemical (700190).
Immunofluorescence
Confocal microscopy was utilized to confirm the mitochondrial localization of the Nudt8
transgene using primary hepatocytes isolated from mice injected with Nudt8-AAV. Hepatocytes
were isolated as described previously (23). Prior to fixation with 4% paraformaldehyde,
hepatocytes were incubated with 25 nM MitoTracker Red CMXRos for 30 minutes at 37 °C.
Following fixation, hepatocytes were blocked in PBS containing 5% FBS and 0.3% Triton-X-100
for 1 hour at room temperature. The FLAG antibody was used at a 1:1000 dilution in 5% BSA
solution prepared in PBS. Following an overnight incubation at 4°C, hepatocytes were washed
10 times with PBS. Following washes, cells were incubated with Alexa Flour 488 secondary
antibody for 1 hour at room temperature. Alexa Flour was used at a 1:500 dilution, in 1% BSA,
0.3% Triton-X-100. Slides were mounted using Prolong Gold Antifade with DAPI (Thermo Fisher).
Imaging experiments were performed at the West Virginia University Imaging Facility using a
Nikon A 1 R/N SIM- E confocal microscope. Image analysis and figures were prepared using
ImageJ.
Tissue Enzymatic Assays
To measure total CoA diphosphohydrolase activity in liver homogenates, 20 mg of frozen
GFP- or Nudt8-AAV liver were homogenized in 750 µL of 20 mM Tris-HCl, pH 8.5. Tissue
homogenates were incubated on ice for 10 minutes and then centrifuged at 20,000 xg for 10
minutes. The supernatant was removed and increasing amounts of protein (50-200 µg) were
incubated with 100 µM mBB-CoA for 10 minutes at 37°C. Reactions were stopped by the addition
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of 20 µL of 20% perchloric acid, neutralized with 22 µL of 2 M potassium carbonate, and incubated
on ice for 10 minutes. Reactions were diluted 5-fold with water and were analyzed via high
pressure liquid chromatography as described previously (17). The amount of 3’,5’-ADP produced
as a result of Nudix activity was determined using a standard curve of 3’,5’-ADP exposed to the
same conditions as those of the reactions.
Subcellular Fractionation
Isolation of mitochondria was performed as described by Graham et al. (24). Briefly, liver
was homogenized in liver homogenization medium (LHM; 200 mM mannitol, 50 mM sucrose, 10
mM potassium chloride, 1 mM EDTA, 10 mM HEPES, pH 7.4) via 5-6 strokes using a Teflon
homogenizer. Lysates were centrifuged at 1,000 xg for 10 minutes at 4°C in a swinging-bucket
rotor. The supernatant was transferred to a 10 mL polycarbonate tube and centrifuged at 3,000
xg using a 70.1 Ti Beckman centrifuge rotor. The resulting supernatant was carefully removed
and transferred to bell top tubes (Beckman # 345829) and centrifuged at 100,000 xg for 1 hour.
The resulting supernatant was removed and served as the cytosolic fraction.
The pellet from the 3,000 xg centrifugation was resuspended in LHM and was centrifuged
at 3,000 xg for 10 minutes. This wash step was repeated twice. Following the final washing step,
the resulting mitochondrial pellet was resuspended in 300 µl of LHM and applied to 8 ml of 30%
percoll in LHM and centrifuged at 95,000 xg for 35 minutes in a 70.1 Ti Beckman centrifuge rotor.
The mitochondrial layer was carefully removed and placed in a clean polycarbonate centrifuge
tube, diluted in 4 volumes of LHM, and centrifuged at 6,300 xg. The resulting pellet was
resuspended in 500 µl of LHM, 400 µl was used for analysis of total CoA and the remaining 100
µl were utilized for protein determination.

Protease Protection Assay
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Protease protection assays were performed as described in Bekeova et. al (25). Briefly,
freshly isolated mitochondria (see above) were resuspended in mitochondrial assay buffer (MAS;
70 mM sucrose, 220 mM mannitol, 10 mM potassium phosphate, 5 mM magnesium chloride, 2
mM HEPES, 0.2% BSA, pH 7.2) to a final concentration of 25 mg/ml. Each reaction totaled 40 µl
of MAS with 100 µg of mitochondrial protein and 0.02 mg/ml proteinase K, unless otherwise noted.
Digitonin was added at the following final concentrations: 0, 0.01%, 0.04%, 0.05%, 0.07%, 0.08%,
0.09%, 0.1% and Triton-X-100 (0.1%), which completely solubilizes the mitochondria, was used
as a positive control. Reactions were incubated at 37°C for 15 minutes. Protease activity was
stopped with the addition of PMSF to a final concentration of 3.25 mM. 10 µl of each fraction were
analyzed for Nudt8 (1:3000), Tim23 (Inner membrane marker; 1: 5000), and citrate synthase
(matrix; 1:1000) via western blotting.
Generation of NIH 3T3 Cells Stably Expressing Nudt8-FLAG
The Nudt8-FLAG lentiviral expression construct was generated by PCR amplifying
Nudt8-FLAG cDNA and inserting it into a pLenti6.3/V5-GW-LacZ (ThermoFisher Scientific)
digested with Eco-RV by Gibson Assembly (New England Biolabs Inc). The integrity of the
insert was confirmed by Sanger Sequencing (WVU Genomic CORE). Lentivirus were generated
in 293FT cells using the ViraPower HiPerform Lentiviral Expression System (ThermoFisher
Scientific) as per manufacturer’s instructions. NIH 3T3 were infected with lentivirus and cells
stably transduced were selected with Blasticidin. Clonal cell lines were screened for Nudt8FLAG by western blot analysis.
APEX Proximity Biotinylation
Apex-mediated biotinylation of proteins localizing to the mitochondrial matrix was
performed as described in Hung et al. (26). Briefly, NIH 3T3 cells stably expressing Nudt8-FLAG
were platted on to two 10 cm dishes and allowed to attach overnight and grow to approximately
70% confluence. Cells were transiently transfected using Lipofectamine 2000 with the APEX2
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plasmid, as per manufacturer’s protocol. The medium was changed 24 hours following
transfection, replaced with DMEM and incubated for another 24 hours. Following incubation, cells
were treated with DMEM containing biotin-phenol (500 µM final concentration) for 30 minutes at
37°C. 100 µl of 100 mM H2O2 was added to the plate and cells were incubated at room
temperature for 5 minutes. Cells were washed with 10 mL quenching solution (10 mM sodium
ascorbate, 5 mM Trolox, and 10 mM sodium azide in PBS) three times at room temperature. Cells
were collected via scraping and lysed in 200 µl lysis buffer consisting of 20 mM HEPES, 100 mM
sodium chloride, 10% glycerol and 1% NP-40. Cell lysates were cleared via centrifugation at
20,000 xg for 10 minutes at 4°C. Nudt8-FLAG was immunoprecipitated using Flag-M2 affinity gel,
as instructed by the manufacturer. Antibodies against citrate synthase (matrix) and cytochrome c
(IMS) were crosslinked to Pierce

TM

A/G Plus Agrose beads using disuccinimidyl suberate as

instructed by the manufacturer. IP eluates were analyzed via western blotting. Elutions were split
and fractionated in parallel gels. Following transfer, one membrane was probed with streptavidinHRP (1:10,000) to assess biotinylation of the eluted protein, and the other membrane was used
to assess the quality of immunoprecipitation.
Total CoA and Acyl-CoA Pool Composition
Total CoA (free CoA plus CoA thioesters) was quantified in livers of AAV-GFP and Nudt8AAV mice using alkaline hydrolysis and derivatization to monobromobimane as described
previously (27). For quantification of total CoA in the mitochondrial and cytosolic fractions, 400 µL
of mitochondrial or cytosolic fractions were added to 1.6 ml of 1 mM potassium hydroxide and
were incubated at 55 °C for 2 hours to hydrolyze all acyl-CoAs to free CoA. Following incubation,
the pH of the samples was adjusted 8 by addition of 160 µL 1 M Trizma- HCl. mBB was added (1
µM final concentration) and samples were incubated in the dark at room temperature for 2 hours.
100 µL of glacial acetic acid was added to acidify samples and the mBB-CoA derivative was
purified using a 2-(2-pyridyl) ethyl-functionalized silica gel column (Supelco). Samples were dried
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using nitrogen flow and were stored at -20°C prior to analysis. Samples were analyzed via high
pressure liquid chromatography as described previously (27).
To determine the effect of Nudt8 over-expression on the (acyl-)CoA pool composition,
CoA species were analyzed using a protocol adapted from Minkler P.E. et al. (28). Samples were
analyzed via LC/MS/MS at the Metabolome Analysis Facility at West Virginia University on an AB
Sciex QTrap 5500 mass spectrometer connected to an AB Sciex Exion UPLC as described
previously (16).
Immunoblotting
For

western

blot

analysis,

flash

frozen

tissues

were

homogenized

in

radioimmunoprecipitation assay buffer containing protease inhibitors and were centrifuged at
10,000 xg for 10 minutes at 4°C. Sample were fractionated by SDS/PAGE on 4-12% Bis-Tris
gels and transferred to PVDF membrane. The Nudt8 antibody, was used at 1:3000 dilution. The
alpha tubulin antibody was used at a 1: 2000 dilution. Primary antibodies were detected using
HRP-conjugated goat anti-rabbit IgG a 1:22,000 dilution.
Results
Submitochondrial Localization of Nudt8
Using immunofluorescence and subcellular fractionation, Nudt8 was shown to localize to
the mitochondria (18). Further, proximity tagging experiments have shown that human NUDT8
localizes to the matrix of the mitochondria (29). To confirm this for the mouse isoform, we utilized
a protease protection assay in which freshly isolated mitochondria were treated with proteinase
K and increasing concentrations of digitonin. Digitonin in a nonionic detergent that binds to
cholesterol disrupting the outer mitochondrial membrane (OMM) in a concentration dependent
manner. At low concentrations of digitonin, the OMM will remain intact and the protease will be
unable to access the inner membrane/matrix. Treatment with intermediate concentration of
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digitonin (0.05%-0.06%) will result in partial disruption of the OMM, and proteins localizing to the
inner membrane (IM) and inner membrane space (IMS) will start to be degraded. At high
concentrations of digitonin, the OMM will be completely solubilized and proteins localizing to the
IM and IMS will be completely degraded. Proteins localizing to the matrix will be protected from
protease degradation throughout digitonin treatments except for treatment with Triton-X-100
which completely solubilizes the mitochondria allowing for the protease to access all mitochondrial
compartments. Tim23, a marker of the inner membrane, was degraded at intermediate
concentrations of digitonin, as expected (Fig. 3.1). While citrate synthase, which resides in the
mitochondrial matrix, was only digested in the Triton-X-100, which completely lyses the
mitochondria. Nudt8 was protected from degradation in all the digitonin conditions and was only
degraded with the addition of Triton-X-100 (Figure 3.1). Overall, the degradation pattern of Nudt8
was identical to that of citrate synthase indicating that it localizes to the mitochondrial matrix.

Figure 3.1. Nudt8 localizes to the mitochondrial matrix. Protease protection experiments were utilized
to determine the submitochondrial localization of Nud8t using proteinase K and increasing concentrations
of digitonin. Mitochondria treated with 0.3% Triton served as positive control as it completely solubilizes
both the outer and inner mitochondrial membranes. Tim23 was used to mark the mitochondrial inner
membrane. Citrate synthase was used to mark the mitochondrial matrix. Representative of three
independent experiments.

To confirm these findings by an independent assay, we utilized proximity tagging using a
ascorbate peroxidase (APEX) localizing to the mitochondrial matrix (29). APEX is an engineered
peroxidase that utilizes hydrogen peroxide to react with biotinylated-phenol. This reaction creates
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a hydroxy radical that covalently reacts with nearby proteins (approximately 20 nm in proximity)
(29). Expression of the APEX within the mitochondrial matrix will result in labeling of the matrix
proteome. Thus, we expected that proteins localizing to the mitochondrial matrix such as Citrate
synthase and Nudt8 would be biotinylated as a result of the APEX expression. Conversely,
proteins that are outside of the mitochondrial matrix, such as cytochrome C should not be
biotinylated. The plasmid encoding APEX was transiently transfected into NIH-3T3 cells stably
expressing Nudt8 with a C-terminal FLAG tag. Biotinylation of Nudt8 was assessed via
immunoprecipitation using the FLAG antibody. Citrate synthase, known to localize to the matrix,
was used as a positive control, and cytochrome C, which localizes to the inter membrane space,
was used as a negative control. Immunoprecipitated proteins were fractionated via SDS-PAGE
and analyzed via western blot. To determine if proteins were biotinylated, membranes were
probed with streptavidin (Fig. 3.2, A and B). As anticipated, biotinylation only occurred with the
expression of the APEX, addition of hydrogen peroxide and biotinylated phenol (Fig. 3.2, A and
B, lane 4). Immunoprecipitated Nudt8 and citrate synthase were detected using the streptavidinHRP conjugate but were not seen in the negative control lacking H2O2 (Fig. 3.2, C-E). However,
probing elution fractions with antibodies for Nudt8 and citrate synthase, respectively, showed that
the immunoprecipitation was successful (Fig. 3.2, D and F). The Nudt8 immunoprecipitation was
performed with an antibody recognizing the FLAG epitope and immunoblotted for Nudt8 using an
antibody that has previously been shown to be specific for the mouse isoform of Nudt8 (18).
Immunoprecipitated cytochrome C, a marker of the intermembrane space was not biotinylated
indicating that biotinylation is specific to the mitochondrial matrix (Fig. 3.2, G-H). Importantly,
using an APEX construct targeted to the mitochondrial inter membrane space, cytochrome C was
biotinylated (30). This supports our conclusion that biotininylation by this matrix targeted APEX
construct is specific to the mitochondrial matrix. Taken together, this confirms the localization of
Nudt8 to the mitochondrial matrix.
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Figure 3.2. APEX mediated proximity biotinylation localizes Nudt8 to the mitochondrial
matrix. A) Transient expression of APEX with a V5 tag in NIH-3T3 cells stably expressing Nudt8FLAG. Nudt8 was identified using antibody recognizing the FLAG epitope. APEX expression was
identified using an antibody against the V5 epitope. B) Biotinylation in cellular lysates of NIH-3T3
cells. Lane 1 (mock transfection), lane 2 (no Biotinylated phenol, BP) and Lane 3 (no H202) served
as negative controls. Lane 4 showed increased biotinylation as a result of the APEX expression
and treatment with BP and H2O2. C-D) Citrate synthase (CS) was immunoprecipitated from cell
lysates. Bioyinylated CS was identified using Strep-HRP conjugated antibody (C). Panel D shows
immunoprecipitated CS as identified by the CS antibody. E-F) (E) shows biotinylation in lane 2 as
identified by Streptavidin-HRP antibody. (F) Immunoprecipitated Nudt8 was identified using Nudt8
antibody. (G-H) Cytochrome C was used as a negative control as it resides in the intermembrane
space. Immunoprecipitated Cyt C was probed with Streptavidin-HRP antibody to identify the
biotinylation (G). Panel H shows immunoprecipitated Cyt C as identified by Cyt C antibody.

Liver Specific Expression of Nudt8 Transgene
Mice injected with Nudt8-AAV experienced a robust expression of the transgene when
compared to non-injected mice (Fig. 3.3, A). Previously, we showed that the ApoE/AAT1 promoter
results in liver specific expression of the transgene (16). As Nudt8 is a mitochondrial protein, we
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wanted to ensure that the transgene was properly localized. To address this, we isolated primary
hepatocytes from mice injected with Nudt8-AAV and utilized immunofluorescence and confocal
microscopy to determine the subcellular localization of the transgene. The transgene was
identified using antibody recognizing the FLAG epitope on the C-terminus of the protein.
Mitochondria were labeled
with

Mitotracker,

and

nuclei with DAPI. FLAGtagged Nudt8 appeared to
have a morphology and
pattern that mirrored that
of the Mitotracker, and the
overlay

the

transgene

largely colocalized with
the Mitotracker (Fig, 3.3
B). We cannot, however,
exclude

that

a

minor

portion of the Nudt8-FLAG
localized

to

other

subcellular compartments.
This could be determined by
immunofluorescence using
additional markers for other

Figure 3.3. Liver specific over-expression of Nudt8 increased the total
CoA-degrading activity in the mitochondria. C57BL/6J mice were
injected with AAV particles to achieve liver-specific overexpression of
Nudt8-Flag or the GFP control. A) Western blot analysis of liver lysates 3weeks following injection of Nudt8-Flag or GFP transgene. B) Primary
hepatocytes were isolated from Nudt8-AAV mice and fixed. The FLAG
antibody was used to visualize the Nudt8 transgene. Mitochondria were
visualized using mitotracker. Cell nuclei were stained with DAPI. The inset
in the merged panel shows higher magnification. C) Liver lysates of Nudt8AAV and GFP injected mice were assayed for total CoA-degrading activity.
Experiments were performed in triplicate. Data are reported as mean ±
SEM.

organelles or by subcellular fractionation techniques. Additionally, background fluorescence from
the FLAG antibody could be determined using a non-injected mouse. Next, we examined the
effect of Nudt8 overexpression on total CoA diphosphohydrolase activity of Nudt8-AAV and GFPAAV liver lysates. To minimize the potential background resulting from Nudt7-mediated CoA
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degradation, the dominant CoA-degrading isoform in the liver, we measured CoA-degrading
activity in tissue harvested following 24-hour fast when Nudt7 expression is lowest (16). The
Nudt8- AAV mice were associated with a 1.5- fold increase in CoA phosphohydrolase activity
compared to GFP controls (Fig. 3.3 C). Taken together, these results show robust expression of
the transgene in the mitochondria, which resulted in increased CoA-degrading activity liver
lysates.
Effect of Nudt8 on Blood Glucose and β-Hydroxybutyrate
In the fasted state, mitochondrial fatty acid β-oxidation relies on an increase in free CoA
generated from CoA biosynthesis (10). Acetyl-CoA generated from fatty acid β-oxidation
contributes to increased flux through the gluconeogenic pathway through allosteric activation of
pyruvate carboxylase (3). Likewise, acetoacetyl-CoA for synthesis of β-hydroxybutyrate is
generated from acetyl-CoA generated
from mitochondrial fatty acid oxidation
(3). Inability to synthesize adequate
amounts of free CoA, in the fasted
state, reduces fatty acid oxidation
resulting in impaired gluconeogenesis
and

ketone

hypothesized

synthesis
that

(10).

We

overexpression

Nudt8 in the mitochondrial matrix

Fig 3.4. Blood glucose and β-hydroxybutyrate were not
affected by Nudt8 over-expression. A) Serum glucose in
the AAV-GFP and AAV Nudt8 in the fed and 24 hour fasted
state. B) β-hydroxybutyrate in serum of fed and 24 hour fasted
AAV-GFP and AAV- Nudt8 mice.

would reduce the availability of free CoA, which in vitro is an excellent substrate for Nudt8 (18).
This reduction in free CoA would reduce the acetyl-CoA generated from mitochondrial fatty acid
oxidation resulting in decreased flux through the gluconeogenic pathway leading to fasting
hypoglycemia and decreased serum β-hydroxybutyrate. Nudt8 overexpression had no effect on
blood glucose or β-hydroxybutyrate in either the fed or the fasted state (Fig.3.4). This suggests
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that the increase in CoA degradation due to Nudt8 overexpression likely did not decrease the free
CoA enough to effect mitochondrial fatty acid oxidation.

Figure 3.5. Mitochondrial and cytosolic total CoA did not change as a result of Nudt8
over-expression. Liver mitochondria and cytosolic fractions were isolated from fed and
24-h fasted Nudt8-AAV and GFP injected mice. Total CoA was measured in each fraction
from ad libitum fed and 24 hour fasted mice. Data are reported as mean ± SEM.

Effect of Nudt8 on the Size and Composition of the CoA Pool
The pool of CoA in the mitochondrial matrix is isolated from the rest of the cell due to the
fact that the mitochondrial inner membrane is impermeable to CoA species. We hypothesized
that overexpression of Nudt8, which would increase CoA-degradation within the mitochondrial
matrix, would decrease total CoA in the mitochondria when compared to the GFP controls.
Mitochondrial and cytosolic fractions from fed and 24 hour fasted Nudt8-AAV and GFP control
mice were obtained by subcellular fractionation. Total CoA was assessed via derivatization with
mBB and quantification by HPLC. There was no significant difference in the magnitude of the total
CoA pool in either the mitochondria or cytosolic fractions in the fasted or the fed state (Figure
3.5).

54

Next, we sought to determine if Nudt8 overexpression had an impact on the composition
of the acyl-CoA pool in liver lysates. In vitro analysis of recombinantly expressed an purified Nudt8
showed it was a promiscuous CoA diphosphohydrolase that readily hydrolyzes free CoA as well
as malonyl-, succinyl-, hexanoyl- and octanoyl-CoA (18). However, longer chain acyl-CoAs could
not be assayed because of precipitation under our enzymatic assay conditions. To determine in
vivo substrates of Nudt8, we analyzed the changes in the composition of the acyl-CoA pool that
occurred as a result of over-expression of the Nudt8 using LC/MS/MS. In the fasted state, there
were no differences in free CoA or acetyl-CoA (Fig. 3.6A). Likewise, there were no differences in

Figure 3.6. Acyl-CoA analysis from 24 hour fasted liver. Acyl-CoA composition was analyzed in 24 hour
fasted Nudt8-AAV and GFP mice via LC/MS/MS. Relative abundance of (A) free and acetyl-CoA, B) Shortchain acyl-CoAs and C) long-chain acyl-CoAs was determined from a total of 6 mice per group. * Indicates
p<0.05. Data is reported as mean ± SEM.

any of the short-chain acyl-CoAs identified by mass spectrometry (Fig. 3.6 B). Examining the
effect of Nudt8 overexpression on long-chain acyl-CoAs, there was a significant decrease in
dodecenoyl-CoA. Additionally, there were small but significant increases in palmitoyl-CoA and
oleoyl-CoA (Fig 3.6 C). Taken together, these results show that overexpression of Nudt8 had no
significant effect on total CoA levels, with minor changes to the composition of the acyl-CoA pool.
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Discussion
Recently, Nudt8 was shown to be a novel CoA diphosphohydrolase that localized to the
mitochondria (18). Here we report that Nudt8 localizes to the mitochondrial matrix, positioning it
to regulate the largest (acyl-) CoA pool in the cell (9). To gain insight into its role in CoA regulation,
we overexpressed Nudt8 in mouse liver using an AAV. Given the localization of Nudt8 to the
mitochondrial matrix, we anticipated that over-expression of Nudt8 would decrease the amount
of one or more CoA species, including free CoA. This decrease in free CoA, in turn, would reduce
acetyl-CoA available for ketogenesis and would also reduce flux through the gluconeogenic
pathway resulting in fasting hypoglycemia. Expression of the transgene resulted in a 1.5- fold
increase in CoA-degrading activity in liver lysates compared to GFP-AAV controls; however, this
modest increases in CoA-degrading activity had no effect on total CoA and only minor changes
to the composition of the acyl-CoA pool (Fig 3.5 and 3.6). The lack of changes, despite an
increase in CoA degradation, can be potentially attributed to compensation by increase in CoA
biosynthesis.
The Nudt8 transgene was correctly localized to the mitochondria. In the liver, mitochondria
have been estimated to contain as much as 80% of the total cellular CoA, with the remaining 20%
distributed amongst the cytosol and the peroxisomes (16,31-33). Increases in CoA degradation
in the peroxisomes through over-expression of the peroxisomal Nudt7 was restricted to the
peroxisomes (16). Thus, we hypothesized that overexpression of mitochondrial Nudt8 would act
to regulate the much larger mitochondrial (acyl-)CoA pool. While expression of the Nudt8
transgene did increase the total CoA-degrading activity detected in the liver of mice injected with
Nudt8-AAV, the magnitude of the total mitochondrial (acyl-)CoA pool was not affected (Fig 3.5).
One potential explanation for the lack of phenotype is compensation by the CoA biosynthetic
pathway. Decreases in mitochondrial CoA due to increased Nudt8 activity could trigger import of
CoA from the cytosol, through active transport into the mitochondrial matrix. Presently two CoA
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transporters belonging to the SLC family of proteins transport CoA, however, the direction of the
transport (i.e. import into the matrix or export from the matrix) has yet to be determined (19,21).
The resulting shift in cytosolic CoA into the mitochondria could, in turn, trigger increase activity of
Pantothenate Kinase (PanK), which would increase CoA biosynthesis returning cytosolic CoA to
normal levels.
The CoA-degrading activity of Nudt8 could also have been mitigated through the activity
of CoA synthase (Coasy) (Fig 3.7). Coasy catalyzes the final two steps in CoA biosynthesis and
has previously been shown to localize to the outer mitochondrial membrane (34). However,
recently, Coasy has been shown to localize to the mitochondrial matrix (29,35). If this finding is
confirmed it places both CoA biosynthetic and CoA-degrading proteins within the same
compartment, raising the question as to how each is regulated to prevent futile cycles of synthesis
and degradation. Nudt8 is not regulated transcriptionally (18) and is thus potentially regulated via
posttranslational modification or allosterically, so that activity is minimized in the fasted state and
maximized in the fed state. While Coasy, on the other hand, would be active in the fasted state to
promote CoA biosynthesis. Despite recent findings localizing Coasy to the mitochondrial matrix,
previous research showed interactions with ribosomal S6 kinase, enhancer of mRNA-decapping
protein 4, and the p85 subunit of PI3 kinase, which contradict the matrix localization as all of these
enzymes are cytosolic (36-40). Thus, determining the subcellular localization of Coasy will be
integral for the understanding of where the cellular CoA pool is synthesized and how it relates to
CoA degradation occurring in the mitochondria.
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Figure 3.7. Compensation of Nudt8 mediated CoA degradation by Coasy. Increase in CoA
degradation due to overexpression of Nudt8 could have been compensated for by the presence of
Coasy. Nudt8 hydrolyzes CoA in to 3’5’-ADP and 4’- phosphopantetheine which, in turn could be
substrate for Coasy localized to the mitochondrial matrix.
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Chapter IV: Conclusions and Future Directions

CoA is an essential cofactor that functions as an acyl-donor and participates in hundreds
of metabolic reactions (1). Beyond its direct participation in metabolic reactions, (acyl-)CoAs,
regulate metabolism through allosteric interactions, and, through post-translational modification,
can regulate protein activity and gene expression (2,3). In this way, changes in the levels of acylCoAs as well as the composition of the (acyl-)CoA pool, can act to ‘fine tune’ gene expression
and protein activity to match the energy needs of the cell. Metabolic processes activated during
fasting, like fatty acid β-oxidation, ketogenesis, and gluconeogenesis are driven by an increase
in free CoA which is achieved through increased CoA synthesis (4). Conversely, the transition
from fatty oxidation to lipogenesis and glucose oxidation is driven by decreased synthesis and
active degradation of free CoA and thioesters. Indeed, simply decreasing the rate of CoA
synthesis would not achieve a net decrease in the concentration of CoA species accumulated
during the fast without CoA/acyl-CoA degradation. Previously, the decrease in total CoA during
the fasted-to- fed transition, in the liver and kidneys, was attributed to the peroxisomal CoAdegrading enzymes Nudt7 and Nudt19 respectively (5). However, deletion of Nudt19 does not
completely prevent the decrease in total CoA levels that characterize the transition from the fasted
to fed state, indicating the presence of other CoA-degrading enzymes (6). Furthermore, while
liver-specific overexpression of Nudt7 in the liver affected peroxisomal lipid metabolism, it had no
detectible effect on total hepatic CoA levels (7). These findings indicate that Nudt7 and Nudt19
likely function to regulate the small peroxisomal (acyl-)CoA pool. However, they also support the
existence of additional CoA-degrading enzymes that regulate the larger mitochondria and
cytosolic (acyl-)CoA pools.
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Nudt8 has been annotated as a CoA-degrading enzyme due to its sequence similarity to
Nudt7. Additionally, Nudt8 was predicted to localize to the mitochondria, the organelles containing
the largest (acyl-)CoA pool in the cell (8,9). The objective of this thesis was to 1) test ability the
ability of Nudt8 to degrade CoA species using recombinantly expressed and purified protein, 2)
determine its tissue distribution and subcellular distribution and 3) establish, in vivo, the
physiological role of Nudt8 regarding (acyl-)CoA regulation.
Conclusions from Chapter II:
To establish Nudt8 as a CoA diphosphohydrolase, we utilized in vitro enzymatic assays
with recombinantly expressed and purified protein. The main finding that emerged from this
approach is that Nudt8 is a CoA-specific diphosphohydrolase that hydrolyzes (acyl-)CoA in to
3’,5’-ADP and (acyl-)phosphopantotheine (10). We found that recombinant Nudt8 was capable of
degrading free CoA as well as a variety of short-, medium- and dicarboxylic acyl-CoAs (10).
Additionally, Nudt8 activity was dependent on the presence of Mn2+. The Nudix motif, common to
all Nudix hydrolase enzymes, binds divalent cation (Mn2+ or Mg2+) which, in turn, binds and
activates a water molecule that ultimately hydrolyzes phosphodiester bonds of the substrate
molecule (11,12). Nudt8 and Nudt7 have a Nudix box that are largely identical, thus the finding
that Nudt8 activity is Mn2+ dependent was unexpected. Finally, we were able to show that Nudt8
is a mitochondrial enzyme and has a broad tissue distribution, as it is expressed the liver, kidneys,
heart, brown adipose tissue and skeletal muscle (10). The mitochondrial localization of Nudt8
positions it to regulate the size and composition of the largest pool of (acyl-)CoA pool in the cell.
Future Directions of Chapter II:
Mitochondria consist of four distinct compartments: the outer membrane, the
intermembrane space (IMS), the inner-membrane, and the matrix. The outer membrane consists
of pores that enable (acyl-)CoAs to freely diffuse into the IMS from the cytosol, thus the (acyl-
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)CoA pool in the IMS and in the cytosol are thought to be at equilibrium (13). The inner membrane
of the mitochondria is impermeable to (acyl-)CoAs, and the matrix pool of free CoA is likely derived
via counter-exchange transporters belonging to the Solute Carrier 25 (SLC25) family of proteins
(14-16). Due to the existence of two separate pools of (acyl-)CoAs within the mitochondria, it was
essential to determine the submitochondrial localization of Nudt8. Localization of Nudt8 to the
IMS would indicate that its activity would function to regulate the IMS/ cytosolic pool of (acyl)CoAs. Conversely, localization of Nudt8 to the mitochondrial matrix would indicate it regulates
the larger pool in the matrix, potentially modulating processes like fatty acid oxidation,
ketogenesis, and gluconeogenesis.
Prior to this work, Nudt8 had been annotated as a CoA-degrading enzyme due to its
similarity to Nudt7. Despite the similarities of Nudt8 and Nudt7 in the CoA binding region and the
Nudix box, we found several important differences between these CoA diphosphohydrolases. The
first difference was the potent activation of Nudt8 by Mn2+. In vitro, Nudt8 activity was completely
dependent on Mn2+ while Nudt7 is able to utilize Mn2+or Mg2+ interchangeably. While Mn2+ and
Mg2+ are usually considered surrogates for each other, Mn2+ forms ligands with nitrogen and sulfur
containing amino acids (eg. histidine, cysteines) and forms bidentate complexes with oxygencontaining ligands, like glutamate, more readily than Mg2+ (17,18). The ligands formed with Mn2+
are more flexible in both length and angle than Mg2+, which adheres to a strict octahedral ligand
binding geometry (18). A second important difference that we saw between Nudt7 and Nudt8
were differences in substrate preferences. While both enzymes are promiscuous CoA-degrading
enzymes, Nudt8 showed the lowest activity towards acetyl-CoA and short-chain acyl-CoAs, which
are preferred substrates of Nudt7 (7,19,20). This raises the question as to whether Nudt8s
requirement of Mn2+ plays a role in the substrate specificity of the enzyme. The ability of Mn 2+ to
form more flexible ligand bonds with amino acids in the Nudix box of Nudt8 may impart a unique
conformation that promotes the binding of dicarboxylic and medium chain acyl-CoAs, at the
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expense of shorter chain acyl-CoAs. To confirm this, the crystal structures of Nudt8 and Nudt7
bound to substrate and divalent cations will be necessary to show exactly how each metal effects
substrate binding and activity of each respective protein.
In the fasted state, CoA levels increase due to increased biosynthesis and decreased
degradation (9). Upon refeeding, there is an increase in (acyl-)CoA degradation that results in a
rapid decrease in tissue (acyl-)CoA levels (7). We hypothesized that Nudt8 expression would
change with the nutritional state, with minimal expression in the fasted state and increased
expression in the fed state. Nudt8 mRNA and protein levels did not change as a result of the
nutritional state in liver, kidney or heart (10). A potential alternative is that Nudt8 activity is
potentially regulated through posttranslational modification (PTM) or allosteric interactions. PTMs
such as acetylation and succinylation are emerging as important regulators of mitochondrial
metabolism, thus Nudt8 activity could potentially be dependent on deacetylases such Sirt3 and
Sirt5 (21-24). To determine if Nudt8 is regulated via post translational modification or proteinprotein interaction, we can utilize immunoprecipitation coupled with either immunoblotting or mass
spectrometry to analyze how Nudt8 is modified and how it changes with nutritional state.
Alternately, Nudt8 activity could be regulated allosterically or competitively through via
mitochondrial metabolites. Alternately, Nudt8 activity could be regulated allosterically or
competitively through via mitochondrial metabolites. Nudt8 also possesses two, predicted,
hydrophobic domains, one on the N-terminus (residues 33-51) and the other towards the Cterminus (residues142-197) (25,26). Nudt8 activity and stability could be regulated through
interaction with lipids, the mitochondrial inner membrane, or other proteins via hydrophobic
interactions. To address this, recombinant Nudt8 activity can be measured in the presence of
mitochondrial lipids and metabolites to determine if there is activation or inhibition.

65

Conclusions Chapter III:
We showed, in vitro, that Nudt8 is a specific CoA diphosphohydrolase that localizes to the
mitochondria (10). Our next aim was to determine the submitocondrial localization of Nudt8 and
to identify metabolic processes effected by Nudt8-mediated CoA degradation. Our main finding
was that Nudt8 localizes to the mitochondrial matrix (Fig 3.1 and 3.2). The mitochondrial matrix
contains the largest concentration of free and acyl-CoA thioesters in the cell, and we hypothesized
that Nudt8 would reduce the CoA and acyl-CoA thioesters within the mitochondrial matrix to
transition from the fasted to the fed state.
To elucidate in vivo substrates of Nudt8, we utilized a liver specific adeno-associated virus
to overexpress Nudt8 in the liver of C57Bl/6J mice. We were able to robustly overexpress the
Nudt8 transgene in the liver and this expression resulted in increased (acyl-)CoA-degrading
activity in liver lysates when compared to GFP injected controls (Fig. 3.3). Despite the increase
in CoA degradation, Nudt8 overexpression had no effect on the total CoA levels in the
mitochondria or cytosolic fractions (Fig. 3.5). Next, we analyzed changes in individual changes in
acyl-CoAs via mass spectrometry and found no significant alterations to the hepatic CoA as a
result of Nudt8 overexpression (Fig. 3.6).
Future Directions Chapter III:
Overexpression of Nudt8 in the liver had no measurable effect on mitochondrial total CoA
levels and only minor changes in the acyl-CoA composition of the liver. One possible explanation
is that the increased degradation of CoA that occurred due to the transgene expression was
compensated for by increased biosynthesis. The decrease in mitochondrial CoA due to Nudt8
overexpression could have resulted in increased importation of cytosolic CoA into the
mitochondria. The resulting decrease in cytosolic CoA would be compensated for through
increased activity of PanK, the rate limiting step in CoA biosynthesis (1). To address this
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hypothesis, we could compare the flux through the CoA biosynthetic pathway using radiolabeled
pantothenate in primary hepatocytes isolated from Nudt8-AAV and GFP-AAV injected mice
respectively. We would expect accumulation of radiolabeled CoA in the Nudt8-AAV indicating
increased CoA biosynthesis.
The presence of CoA synthase (Coasy) in the mitochondria presents an alternate means
through which CoA biosynthesis could compensate for increased Nudt8 mediated CoAdegradation. Coasy is a bifunctional enzyme that catalyzes the formation of dephospho-CoA from
4’-phosphopantotheine as well as phosphorylation of dephospho-CoA to CoA, the final step in
CoA biosynthesis. Initially, Coasy was thought to localize to the outer membrane of the
mitochondria, however, more recently it was found to localize to the matrix (27,28). If Coasy does
in fact localize to the mitochondrial matrix, then 4’-phosphopantotheine generated from Nudt8
could be reincorporated into CoA by Coasy, mitigating the activity of Nudt8 (Fig. 3.7). This raises
the question as to how biosynthesis (Coasy) and degradation (Nudt8), within the mitochondria,
are regulated to prevent futile cycles of synthesis and degradation. Coasy has been shown to
interact with multiple proteins effecting its activity including enhancer of mRNA- decapping 4
(EDC4), p85, and S6K1 (29-33). The effect of these interactions on CoA biosynthesis have not
been elucidated in vivo. However, interaction with EDC4 and phosphorylation via S6K1 are likely
inhibitory (29,33). Interestingly, these interacting proteins are cytosolic, and thus it presently
unclear how they can act to regulate Coasy activity within the mitochondria. One potential
explanation is the localization of Coasy in the mitochondrial matrix as well as the cytosol. To
address this hypothesis, we could utilize simple subcellular fractionation techniques to isolate
mitochondrial and cytosolic fractions and look for Coasy expression in each respective fraction.
Next, we can immunoprecipitated Coasy from mitochondrial and cytosolic fractions from fasted
and fed tissues and examine differences in post translational modifications and protein-protein
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interactions. This will provide insight into 1) if two separate pools of Coasy exist and 2) identify an
alternate mechanism through which CoA biosynthesis is regulated.
Conclusion:
Nudt8 is a novel CoA diphosphohydrolase that localizes to the mitochondrial matrix. The
discovery of Nudt8 has identified a potentially important mechanism for regulating mitochondrial
(acyl-)CoA levels and thus mitochondrial metabolism. The mitochondria contain between 80%95% of the total cellular CoA supporting flux through the TCA cycle, fatty acid β-oxidation,
ketogenesis and gluconeogenesis (9). The fast to fed transition in the liver, kidney and heart is
associated with a dramatic decrease in free CoA, which is abundant in the mitochondrial matrix
(9,34). In vitro, free CoA is readily hydrolyzed by Nudt8, thus it could function to reduce the
availability of free CoA for fatty acid oxidation within the mitochondrial matrix (10). Additionally,
Nudt8 could function to regulate long-chain acyl-CoAs, however, we were not able to test this
activity in vitro due to substrate precipitation.
Additionally, the finding that Nudt8 and Coasy localize to the mitochondrial matrix raises
the question of how CoA degradation and biosynthesis are regulated within the mitochondria, as
well as where CoA is ultimately synthesized. Previously, it was thought that Coasy localized to
the outer mitochondrial membrane, thus its activity would result in the accumulation of newly
synthesized CoA in the cytosol (35). However, the recent finding Coasy localizes to the
mitochondrial matrix challenges this paradigm (27,28). As phosphopantetheine is negatively
charged and exhibits very limited ability to passively diffuse across membranes, it would require
a transporter that, to this point, has not been identified (36). Furthermore, if the final two steps of
CoA biosynthesis occur in the mitochondria, the rate of CoA biosynthesis would be dependent on
the rate at which phosphopantheine can be imported into the mitochondrial matrix and the rate at
which newly synthesized CoA can be exported. Since PANK enzymes are well known to act as
sensors of CoA levels in the cytosol, nucleus and mitochondrial IMS, which can equilibrate
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metabolites within the cytosol, a scenario in which CoA is synthesized in the mitochondrial matrix
is hard to reconcile with this evidence. Due to the fact that Coasy interacts with multiple proteins
known to localize outside the mitochondria, it is likely that Coasy localizes to both the mitochondria
and the cytosol. The cytosolic Coasy could function as the primary site of CoA biosynthesis, while
the mitochondrial Coasy could function to regenerate CoA from the phosphopantetheine
produced by Nudt8.
Alternatively, as no PANK isoform localizes to the mitochondrial matrix, Nudt8 and Coasy
could act cooperatively, acting as local sensors for free CoA and could modify the acyl-CoA/ free
CoA ratio. In conditions where free CoA is limiting, 3’,5’-ADP generated from Nudt8- mediated
degradation of acyl-CoAs activity could stimulate the import of free CoA into the mitochondrial
matrix via the SLC25A42 and SLC25A16 transport proteins. The acyl-phosphopantetheine
generated by Nudt8, could be hydrolyzed by an acyl-CoA thioesterase and the resulting
phosphopantetheine then could serve as substrate for Coasy. This would essentially result in the
generation of two free CoA molecules and alter the acyl-CoA/ CoA ratio within the mitochondria.
This could prove advantageous in situations when free CoA is limiting. Future studies, including
the generation of a Nudt8-/- mouse are needed to elucidate how Nudt8 regulates the mitochondrial
CoA pool and thus mitochondrial metabolism.
In conclusion, we have identified Nudt8 as a novel CoA diphosphohydrolase that localizes
to the mitochondrial matrix. Further, we have shown that CoA degradation occurs outside of the
peroxisomes and in a broad array of tissues including the liver, kidney, heart, brown adipose
tissue and skeletal muscle. Overall, this discovery has identified a novel mechanism through
which the mitochondrial acyl-CoAs are regulated.
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